| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 6.57e-09 | 40 | 130 | 7 | GO:0140662 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 2.45e-08 | 73 | 130 | 8 | GO:0044183 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 1.85e-07 | 39 | 130 | 6 | GO:0097718 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MCM8 CCT2 OLA1 SRCAP DNAH7 ABCB10 ABCA5 CHD6 DDX41 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 1.91e-07 | 441 | 130 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MCM8 CCT2 OLA1 SRCAP DNAH7 KIF24 ABCB10 ABCA5 CHD6 DDX41 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 2.49e-06 | 614 | 130 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 5.32e-06 | 6 | 130 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 5.32e-06 | 6 | 130 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.16e-05 | 163 | 130 | 8 | GO:0031072 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 1.87e-05 | 126 | 130 | 7 | GO:0051082 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 9.31e-05 | 14 | 130 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 1.16e-04 | 15 | 130 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | denatured protein binding | 1.26e-04 | 3 | 130 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MCM8 CCT2 OLA1 SRCAP DNAH7 ABCB10 ABCA5 CHD6 DDX41 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 1.59e-04 | 775 | 130 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | protein domain specific binding | DAB2IP EZR CACNB2 ZMYND8 XRCC4 CREBBP USP8 RAPGEF2 RIMS2 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 SH3BP5 | 1.83e-04 | 875 | 130 | 16 | GO:0019904 |
| GeneOntologyMolecularFunction | misfolded protein binding | 2.05e-04 | 18 | 130 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | UTP binding | 2.50e-04 | 4 | 130 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 2.50e-04 | 4 | 130 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.56e-04 | 93 | 130 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MCM8 CCT2 OLA1 SRCAP DNAH7 ABCB10 ABCA5 CHD6 DDX41 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 3.73e-04 | 839 | 130 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MCM8 CCT2 OLA1 SRCAP DNAH7 ABCB10 ABCA5 CHD6 DDX41 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 3.77e-04 | 840 | 130 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MCM8 CCT2 OLA1 SRCAP DNAH7 ABCB10 ABCA5 CHD6 DDX41 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 3.77e-04 | 840 | 130 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | death receptor agonist activity | 4.15e-04 | 5 | 130 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 4.15e-04 | 5 | 130 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 8.02e-04 | 231 | 130 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 8.65e-04 | 7 | 130 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | phospholipid binding | DAB2IP APOE NUP35 ITPR2 ESYT3 SCARB1 ARHGAP44 PNPLA3 RAPGEF2 EPN1 HSPA8 | 9.23e-04 | 548 | 130 | 11 | GO:0005543 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.47e-03 | 9 | 130 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.47e-03 | 9 | 130 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 1.66e-03 | 337 | 130 | 8 | GO:0031625 | |
| GeneOntologyMolecularFunction | histone binding | 1.77e-03 | 265 | 130 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DAB2IP DOCK2 PLEKHG7 RGPD1 ARFGEF3 ARHGEF10 ARHGAP44 RPGR RAPGEF2 SH3BP5 | 1.79e-03 | 507 | 130 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DAB2IP DOCK2 PLEKHG7 RGPD1 ARFGEF3 ARHGEF10 ARHGAP44 RPGR RAPGEF2 SH3BP5 | 1.79e-03 | 507 | 130 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 2.23e-03 | 11 | 130 | 2 | GO:0019103 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 2.41e-03 | 358 | 130 | 8 | GO:0044389 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.60e-03 | 446 | 130 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | tau protein binding | 3.34e-03 | 46 | 130 | 3 | GO:0048156 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.34e-03 | 46 | 130 | 3 | GO:0005245 | |
| GeneOntologyBiologicalProcess | protein refolding | 2.55e-08 | 30 | 127 | 6 | GO:0042026 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 1.82e-07 | 41 | 127 | 6 | GO:0051084 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 3.70e-07 | 46 | 127 | 6 | GO:0006458 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 2.29e-06 | 35 | 127 | 5 | GO:0051085 | |
| GeneOntologyBiologicalProcess | response to unfolded protein | 3.79e-06 | 148 | 127 | 8 | GO:0006986 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | DAB2IP CACNB2 CACNB3 APAF1 RGPD1 TSC1 CCT2 RIPK4 CAMK1 APOE XRCC4 CREBBP ADCY3 CHUK CFLAR ARHGEF10 SCARB1 ARHGAP44 RAPGEF2 HSPA1A HSPA1B HSPA2 EIF2AK2 HSP90AA1 | 5.99e-06 | 1430 | 127 | 24 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 7.56e-06 | 21 | 127 | 4 | GO:0090083 | |
| GeneOntologyBiologicalProcess | response to topologically incorrect protein | 8.85e-06 | 166 | 127 | 8 | GO:0035966 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 1.00e-05 | 80 | 127 | 6 | GO:0061077 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | VPS13C RGPD1 MYRIP VPS26A CAMK1 NUP35 MTX2 GRK3 ARHGAP44 VPS13A RPGR RIMS2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 1.28e-05 | 740 | 127 | 16 | GO:0006886 |
| GeneOntologyBiologicalProcess | protein folding | 2.20e-05 | 246 | 127 | 9 | GO:0006457 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | USP53 CACNB3 APAF1 TSC1 HMOX2 XRCC4 ECE1 CREBBP CHUK ITPR2 CFLAR POSTN PARP1 KARS1 VPS13A RPGR MAPK13 HSPA1A HSPA1B HSPA2 HSPA8 HSP90AA1 | 2.77e-05 | 1361 | 127 | 22 | GO:0009628 |
| GeneOntologyBiologicalProcess | localization within membrane | DOCK2 CACNA1A EZR CACNB2 CACNB3 ZMYND8 VPS26A APOE MTX2 ARHGAP44 KCNIP4 RAPGEF2 HECTD1 HSPA5 AP3D1 HSP90AA1 | 3.22e-05 | 798 | 127 | 16 | GO:0051668 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DAB2IP EZR ZMYND8 TSC1 SIX4 APOE KIF24 ARHGEF10 ARHGAP44 RAPGEF2 EPN1 HSPA1A HSPA1B HSPA2 EIF2AK2 ODAD3 HSPA5 PLK4 HSPA8 HSP90AA1 | 3.87e-05 | 1189 | 127 | 20 | GO:0044087 |
| GeneOntologyBiologicalProcess | protein localization to organelle | EZR MCM8 VPS13C TTC21A ZMYND8 RGPD1 CCT2 SIX4 XRCC4 CREBBP NUP35 PARP1 MTX2 GRK2 VPS13A HSPA5 AP3D1 HSPA8 HSP90AA1 | 3.88e-05 | 1091 | 127 | 19 | GO:0033365 |
| GeneOntologyBiologicalProcess | intracellular transport | EZR VPS13C TTC21A IFT81 RGPD1 MYRIP TSC1 VPS26A CAMK1 APOE NUP35 MTX2 GRK3 ARHGAP44 VPS13A RPGR RIMS2 HSPA1A HSPA1B HSPA5 AP3D1 HSPA8 HSP90AA1 | 3.89e-05 | 1496 | 127 | 23 | GO:0046907 |
| GeneOntologyBiologicalProcess | activation of innate immune response | DAB2IP CREBBP CHUK PARP1 OTULIN HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 4.14e-05 | 333 | 127 | 10 | GO:0002218 |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 4.82e-05 | 12 | 127 | 3 | GO:0090084 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 4.88e-05 | 33 | 127 | 4 | GO:0070841 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | EZR CAD ESRRB CREBBP ADCY3 ITPR2 CFLAR POSTN USP8 PARP1 GRK2 PNPLA3 RAPGEF2 HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 7.56e-05 | 1048 | 127 | 18 | GO:0014070 |
| GeneOntologyBiologicalProcess | synapse organization | DAB2IP CACNA1A EZR CACNB2 CACNB3 ZMYND8 TSC1 CAMK1 SIX4 APOE ARHGAP44 RAPGEF2 RIMS2 HSPA8 | 8.46e-05 | 685 | 127 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 8.55e-05 | 228 | 127 | 8 | GO:0045732 | |
| GeneOntologyBiologicalProcess | regulation of protein stability | DSC3 MCM8 TSC1 CCT2 CREBBP USP8 HSPA1A HSPA1B HSPA8 HSP90AA1 | 9.52e-05 | 368 | 127 | 10 | GO:0031647 |
| GeneOntologyBiologicalProcess | response to heat | 1.04e-04 | 121 | 127 | 6 | GO:0009408 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | CACNA1A EZR CACNB2 CACNB3 ZMYND8 APOE MTX2 ARHGAP44 KCNIP4 RAPGEF2 HECTD1 HSPA5 AP3D1 HSP90AA1 | 1.15e-04 | 705 | 127 | 14 | GO:0072657 |
| GeneOntologyBiologicalProcess | activation of immune response | DAB2IP EZR CACNB3 CREBBP CHUK PARP1 OTULIN C4BPB HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 1.25e-04 | 623 | 127 | 13 | GO:0002253 |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 1.37e-04 | 312 | 127 | 9 | GO:0002758 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 1.44e-04 | 81 | 127 | 5 | GO:0034605 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle remodeling | 1.46e-04 | 17 | 127 | 3 | GO:0034375 | |
| GeneOntologyBiologicalProcess | protein catabolic process | DAB2IP EZR SLC6A17 WWP1 PSMA4 APOE UBE2U USP8 SAMD9L VPS13A C4BPB RPGR HSPA1A HECTD1 HSPA1B HSPA5 HSPA8 HSP90AA1 | 1.65e-04 | 1115 | 127 | 18 | GO:0030163 |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process | DAB2IP EZR APOE USP8 SAMD9L C4BPB HSPA1A HECTD1 HSPA1B HSP90AA1 | 2.16e-04 | 407 | 127 | 10 | GO:0042176 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DAB2IP CACNA1A EZR CDHR2 ZMYND8 TSC1 CAMK1 APOE KIF24 CFLAR ARHGAP44 RAPGEF2 ODAD3 HSPA5 HSP90AA1 | 2.24e-04 | 846 | 127 | 15 | GO:0120035 |
| GeneOntologyBiologicalProcess | protein targeting to vacuole | 2.34e-04 | 49 | 127 | 4 | GO:0006623 | |
| GeneOntologyBiologicalProcess | cellular response to epidermal growth factor stimulus | 2.34e-04 | 49 | 127 | 4 | GO:0071364 | |
| GeneOntologyBiologicalProcess | nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.41e-04 | 20 | 127 | 3 | GO:0070431 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DAB2IP DOCK2 ZMYND8 TSC1 CCT2 CAMK1 APOE XRCC4 CFLAR USP8 ARHGEF10 RAPGEF2 RIMS2 EPN1 HSPA1A HSPA1B HSPA5 PLK4 HSPA8 HSP90AA1 | 2.55e-04 | 1366 | 127 | 20 | GO:0051130 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DAB2IP CACNA1A EZR CDHR2 ZMYND8 TSC1 CAMK1 APOE KIF24 CFLAR ARHGAP44 RAPGEF2 ODAD3 HSPA5 HSP90AA1 | 2.77e-04 | 863 | 127 | 15 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of innate immune response | DAB2IP CREBBP CHUK PARP1 OTULIN HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 2.77e-04 | 420 | 127 | 10 | GO:0045089 |
| GeneOntologyBiologicalProcess | reverse cholesterol transport | 2.80e-04 | 21 | 127 | 3 | GO:0043691 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response | DAB2IP CREBBP CHUK PARP1 KARS1 OTULIN MAPK13 HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 2.86e-04 | 589 | 127 | 12 | GO:0031349 |
| GeneOntologyBiologicalProcess | chromosome organization | MCM8 TENT4A ASCC1 CCT2 XRCC4 UBE2U PARP1 TDRD3 ARHGEF10 HSPA1A HSPA1B HSPA2 HSP90AA1 | 3.19e-04 | 686 | 127 | 13 | GO:0051276 |
| GeneOntologyBiologicalProcess | response to epidermal growth factor | 3.42e-04 | 54 | 127 | 4 | GO:0070849 | |
| GeneOntologyBiologicalProcess | positive regulation of NF-kappaB transcription factor activity | 3.48e-04 | 151 | 127 | 6 | GO:0051092 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | EZR ESRRB ADCY3 ITPR2 CFLAR USP8 PARP1 PNPLA3 RAPGEF2 HSPA1A HSPA1B HSPA8 | 3.64e-04 | 605 | 127 | 12 | GO:0071407 |
| GeneOntologyBiologicalProcess | regulation of innate immune response | DAB2IP APOE CREBBP CHUK PARP1 OTULIN HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 3.70e-04 | 519 | 127 | 11 | GO:0045088 |
| GeneOntologyBiologicalProcess | positive regulation of high voltage-gated calcium channel activity | 3.72e-04 | 5 | 127 | 2 | GO:1901843 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid fibril formation | 3.72e-04 | 5 | 127 | 2 | GO:1905908 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 3.72e-04 | 5 | 127 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | cellular response to unfolded protein | 3.86e-04 | 100 | 127 | 5 | GO:0034620 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 4.12e-04 | 362 | 127 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | protein maturation | RGPD1 TSC1 CCT2 ECE1 CREBBP PARP1 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 4.47e-04 | 619 | 127 | 12 | GO:0051604 |
| GeneOntologyBiologicalProcess | chaperone-mediated protein complex assembly | 4.75e-04 | 25 | 127 | 3 | GO:0051131 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 4.75e-04 | 25 | 127 | 3 | GO:2001224 | |
| GeneOntologyBiologicalProcess | pattern recognition receptor signaling pathway | 4.80e-04 | 294 | 127 | 8 | GO:0002221 | |
| GeneOntologyBiologicalProcess | positive regulation of response to biotic stimulus | DAB2IP CREBBP CHUK PARP1 OTULIN HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 4.85e-04 | 451 | 127 | 10 | GO:0002833 |
| GeneOntologyBiologicalProcess | hemopoiesis | DOCK2 WWP1 IRF8 TSC1 XRCC4 SBNO2 CHUK CFLAR PARP1 SAMD9L ABCB10 VPS13A HSPA1A HECTD1 HSPA1B EIF2AK2 AP3D1 HSP90AA1 | 5.03e-04 | 1223 | 127 | 18 | GO:0030097 |
| GeneOntologyBiologicalProcess | regulation of presynaptic cytosolic calcium ion concentration | 5.34e-04 | 26 | 127 | 3 | GO:0099509 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 5.55e-04 | 6 | 127 | 2 | GO:0070370 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 6.13e-04 | 168 | 127 | 6 | GO:0000723 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | DAB2IP EZR CACNB3 CREBBP CHUK PARP1 OTULIN HSPA1A HSPA1B EIF2AK2 HSPA8 | 6.28e-04 | 553 | 127 | 11 | GO:0002757 |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 6.94e-04 | 65 | 127 | 4 | GO:0098815 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 7.07e-04 | 239 | 127 | 7 | GO:0071383 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | DAB2IP EZR CACNB3 CREBBP CHUK PARP1 KARS1 OTULIN C4BPB HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 7.15e-04 | 845 | 127 | 14 | GO:0050778 |
| GeneOntologyBiologicalProcess | establishment of protein localization to vacuole | 7.36e-04 | 66 | 127 | 4 | GO:0072666 | |
| GeneOntologyBiologicalProcess | response to oxidative stress | 7.59e-04 | 478 | 127 | 10 | GO:0006979 | |
| GeneOntologyBiologicalProcess | cellular response to topologically incorrect protein | 7.60e-04 | 116 | 127 | 5 | GO:0035967 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 7.74e-04 | 7 | 127 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine maintenance | 7.74e-04 | 7 | 127 | 2 | GO:1902952 | |
| GeneOntologyBiologicalProcess | heat acclimation | 7.74e-04 | 7 | 127 | 2 | GO:0010286 | |
| GeneOntologyBiologicalProcess | regulation of microvillus length | 7.74e-04 | 7 | 127 | 2 | GO:0032532 | |
| GeneOntologyBiologicalProcess | protein stabilization | 7.79e-04 | 243 | 127 | 7 | GO:0050821 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CACNA1A CACNB3 ZMYND8 APOE SCGN USP8 GRK2 ARHGAP44 VPS13A SV2C RAPGEF2 RIMS2 | 8.17e-04 | 663 | 127 | 12 | GO:0050804 |
| GeneOntologyBiologicalProcess | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 8.20e-04 | 30 | 127 | 3 | GO:0035872 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CACNA1A CACNB3 ZMYND8 APOE SCGN USP8 GRK2 ARHGAP44 VPS13A SV2C RAPGEF2 RIMS2 | 8.27e-04 | 664 | 127 | 12 | GO:0099177 |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 8.70e-04 | 69 | 127 | 4 | GO:0050881 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | DAB2IP MTF2 IRF8 SBNO2 NUP35 CHUK POSTN GRK2 OTULIN STIP1 MAPK13 DDX41 HSPA1A HSPA1B HSPA5 | 9.01e-04 | 967 | 127 | 15 | GO:0071345 |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 9.18e-04 | 70 | 127 | 4 | GO:0060999 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | TTC21A IFT81 DNAH7 KIF24 ADCY3 VPS13A RPGR ODAD3 AP3D1 HSPA8 | 9.60e-04 | 493 | 127 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | cell junction organization | DAB2IP CACNA1A EZR CACNB2 CACNB3 ZMYND8 TSC1 CAMK1 SIX4 APOE POF1B ARHGAP44 RAPGEF2 RIMS2 HSPA8 | 9.69e-04 | 974 | 127 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | response to ketone | 1.01e-03 | 254 | 127 | 7 | GO:1901654 | |
| GeneOntologyBiologicalProcess | response to cytokine | DAB2IP MTF2 IRF8 SBNO2 NUP35 CHUK POSTN GRK2 OTULIN STIP1 MAPK13 DDX41 HSPA1A HSPA1B EIF2AK2 HSPA5 | 1.01e-03 | 1083 | 127 | 16 | GO:0034097 |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 1.03e-03 | 8 | 127 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 1.03e-03 | 8 | 127 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 1.07e-03 | 187 | 127 | 6 | GO:0007034 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 1.07e-03 | 73 | 127 | 4 | GO:0050879 | |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 1.10e-03 | 188 | 127 | 6 | GO:0002753 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.12e-03 | 335 | 127 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-binding transcription factor activity | 1.18e-03 | 261 | 127 | 7 | GO:0051091 | |
| GeneOntologyBiologicalProcess | microvillus organization | 1.19e-03 | 34 | 127 | 3 | GO:0032528 | |
| GeneOntologyBiologicalProcess | response to peptide | DAB2IP MTF2 IRF8 SBNO2 NUP35 CHUK POSTN GRK2 OTULIN STIP1 MAPK13 DDX41 HSPA1A HSPA1B EIF2AK2 HSPA5 | 1.19e-03 | 1100 | 127 | 16 | GO:1901652 |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 1.22e-03 | 129 | 127 | 5 | GO:0039531 | |
| GeneOntologyBiologicalProcess | viral life cycle | 1.23e-03 | 340 | 127 | 8 | GO:0019058 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in cell | 1.25e-03 | 76 | 127 | 4 | GO:0032507 | |
| GeneOntologyBiologicalProcess | regulation of pattern recognition receptor signaling pathway | 1.26e-03 | 193 | 127 | 6 | GO:0062207 | |
| GeneOntologyBiologicalProcess | positive regulation of voltage-gated calcium channel activity | 1.32e-03 | 9 | 127 | 2 | GO:1901387 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | VPS13C RGPD1 CCT2 NUP35 MTX2 VPS13A HSPA5 AP3D1 HSPA8 HSP90AA1 | 1.33e-03 | 515 | 127 | 10 | GO:0072594 |
| GeneOntologyBiologicalProcess | positive regulation of supramolecular fiber organization | 1.36e-03 | 196 | 127 | 6 | GO:1902905 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle remodeling | 1.40e-03 | 36 | 127 | 3 | GO:0034369 | |
| GeneOntologyBiologicalProcess | protein-lipid complex remodeling | 1.40e-03 | 36 | 127 | 3 | GO:0034368 | |
| GeneOntologyBiologicalProcess | telomere organization | 1.47e-03 | 199 | 127 | 6 | GO:0032200 | |
| GeneOntologyCellularComponent | dendritic shaft | 9.14e-05 | 74 | 128 | 5 | GO:0043198 | |
| GeneOntologyCellularComponent | protein folding chaperone complex | 1.25e-04 | 42 | 128 | 4 | GO:0101031 | |
| GeneOntologyCellularComponent | photoreceptor ribbon synapse | 1.71e-04 | 18 | 128 | 3 | GO:0098684 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.79e-04 | 46 | 128 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | myelin sheath | 3.86e-04 | 217 | 128 | 7 | GO:0043209 | |
| GeneOntologyCellularComponent | sperm midpiece | 6.41e-04 | 64 | 128 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | melanosome | 6.59e-04 | 113 | 128 | 5 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 6.59e-04 | 113 | 128 | 5 | GO:0048770 | |
| GeneOntologyCellularComponent | centriole | 6.74e-04 | 172 | 128 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | ribbon synapse | 9.77e-04 | 32 | 128 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 1.00e-03 | 124 | 128 | 5 | GO:1904813 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | VPS13C SLC6A17 VPS26A HMOX2 APOE SCGN ECE1 ITPR2 ARFGEF3 USP8 ABCA5 SCARB1 VPS13A SV2C EPN1 AP3D1 HSPA8 SH3BP5 | 1.02e-03 | 1307 | 128 | 18 | GO:0030659 |
| GeneOntologyCellularComponent | calcium channel complex | 1.05e-03 | 73 | 128 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | vesicle membrane | VPS13C SLC6A17 VPS26A HMOX2 APOE SCGN ECE1 ITPR2 ARFGEF3 USP8 ABCA5 SCARB1 VPS13A SV2C EPN1 AP3D1 HSPA8 SH3BP5 | 1.19e-03 | 1325 | 128 | 18 | GO:0012506 |
| GeneOntologyCellularComponent | secretory granule | DOCK2 VPS13C APAF1 MYRIP CCT2 HMOX2 OLA1 ECE1 ITPR2 USP8 VPS13A HSPA1A HSPA1B HSPA8 HSP90AA1 | 1.37e-03 | 1014 | 128 | 15 | GO:0030141 |
| GeneOntologyCellularComponent | secretory vesicle | DOCK2 VPS13C SLC6A17 APAF1 MYRIP CCT2 HMOX2 OLA1 ECE1 ITPR2 USP8 VPS13A SV2C HSPA1A HSPA1B HSPA8 HSP90AA1 | 1.57e-03 | 1246 | 128 | 17 | GO:0099503 |
| GeneOntologyCellularComponent | microvillus membrane | 1.62e-03 | 38 | 128 | 3 | GO:0031528 | |
| GeneOntologyCellularComponent | COP9 signalosome | 1.62e-03 | 38 | 128 | 3 | GO:0008180 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SERHL2 EZR RGPD1 MYRIP TSC1 SRCAP ECE1 GRK3 RAPGEF2 HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 1.76e-03 | 934 | 128 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PRPF31 TENT4A MTF2 ESRRB RGPD1 ERI1 XRCC4 SRCAP CREBBP NUP35 TDRD3 BRD9 MED23 DDX41 HSPA1A HSPA1B HSPA5 HSPA8 | 1.83e-03 | 1377 | 128 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | blood microparticle | 1.94e-03 | 144 | 128 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | zona pellucida receptor complex | 1.97e-03 | 11 | 128 | 2 | GO:0002199 | |
| GeneOntologyCellularComponent | inclusion body | 2.28e-03 | 90 | 128 | 4 | GO:0016234 | |
| GeneOntologyCellularComponent | dendrite | DAB2IP CACNA1A ZMYND8 APOE SCGN USP8 GRK2 GRK3 ARHGAP44 KCNIP4 HSPA5 HSPA8 HSP90AA1 | 2.34e-03 | 858 | 128 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 2.36e-03 | 12 | 128 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP CACNA1A ZMYND8 APOE SCGN USP8 GRK2 GRK3 ARHGAP44 KCNIP4 HSPA5 HSPA8 HSP90AA1 | 2.39e-03 | 860 | 128 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | terminal bouton | 2.89e-03 | 96 | 128 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | presynapse | CACNA1A CACNB2 CAD SLC6A17 SCGN GRK2 GRK3 ARHGAP44 SV2C RIMS2 EPN1 AP3D1 HSPA8 | 3.09e-03 | 886 | 128 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | apical plasma membrane | 3.10e-03 | 487 | 128 | 9 | GO:0016324 | |
| Domain | HSP70 | 5.75e-08 | 16 | 128 | 5 | PF00012 | |
| Domain | HSP70_2 | 8.10e-08 | 17 | 128 | 5 | PS00329 | |
| Domain | HSP70_1 | 8.10e-08 | 17 | 128 | 5 | PS00297 | |
| Domain | HSP70_3 | 8.10e-08 | 17 | 128 | 5 | PS01036 | |
| Domain | Hsp_70_fam | 1.11e-07 | 18 | 128 | 5 | IPR013126 | |
| Domain | - | 9.98e-07 | 12 | 128 | 4 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 9.98e-07 | 12 | 128 | 4 | IPR029047 | |
| Domain | - | 1.43e-06 | 13 | 128 | 4 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.43e-06 | 13 | 128 | 4 | IPR018181 | |
| Domain | HSP70_C | 1.43e-06 | 13 | 128 | 4 | IPR029048 | |
| Domain | VPS13 | 1.39e-04 | 3 | 128 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.39e-04 | 3 | 128 | 2 | PF16910 | |
| Domain | VPS13 | 1.39e-04 | 3 | 128 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.39e-04 | 3 | 128 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.39e-04 | 3 | 128 | 2 | IPR031642 | |
| Domain | VDCC_L_bsu | 2.77e-04 | 4 | 128 | 2 | IPR000584 | |
| Domain | SHR-BD | 2.77e-04 | 4 | 128 | 2 | IPR009543 | |
| Domain | VPS13_C | 2.77e-04 | 4 | 128 | 2 | PF16909 | |
| Domain | VGCC_beta4Aa_N | 2.77e-04 | 4 | 128 | 2 | PF12052 | |
| Domain | VPS13_C | 2.77e-04 | 4 | 128 | 2 | IPR031645 | |
| Domain | SHR-BD | 2.77e-04 | 4 | 128 | 2 | PF06650 | |
| Domain | Autophagy-rel_C | 4.60e-04 | 5 | 128 | 2 | IPR015412 | |
| Domain | ATG_C | 4.60e-04 | 5 | 128 | 2 | PF09333 | |
| Domain | PROTEIN_KINASE_ST | 8.81e-04 | 362 | 128 | 9 | PS00108 | |
| Domain | GPCR_kinase | 9.57e-04 | 7 | 128 | 2 | IPR000239 | |
| Domain | Pkinase | 1.26e-03 | 381 | 128 | 9 | PF00069 | |
| Domain | Chorein_N | 1.27e-03 | 8 | 128 | 2 | PF12624 | |
| Domain | VPS13_N | 1.27e-03 | 8 | 128 | 2 | IPR026854 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 2.10e-08 | 13 | 101 | 5 | MM14952 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 3.86e-08 | 28 | 101 | 6 | M27254 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.67e-07 | 38 | 101 | 6 | M27255 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.97e-07 | 92 | 101 | 8 | MM14951 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 5.19e-07 | 23 | 101 | 5 | MM14953 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.12e-07 | 101 | 101 | 8 | M27253 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 8.69e-07 | 73 | 101 | 7 | MM14948 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.82e-06 | 52 | 101 | 6 | MM14949 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.14e-06 | 57 | 101 | 6 | M27251 | |
| Pathway | KEGG_ENDOCYTOSIS | 5.89e-06 | 181 | 101 | 9 | M1519 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 7.47e-06 | 66 | 101 | 6 | MM17074 | |
| Pathway | WP_MAPK_SIGNALING | CACNA1A CACNB2 CACNB3 CHUK RAPGEF2 MAPK13 HSPA1A HSPA1B HSPA2 HSPA8 | 1.04e-05 | 246 | 101 | 10 | M39597 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.70e-05 | 76 | 101 | 6 | M48037 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | CACNA1A CACNB2 CACNB3 CHUK RAPGEF2 MAPK13 HSPA1A HSPA1B HSPA2 HSPA8 | 2.12e-05 | 267 | 101 | 10 | M10792 |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.63e-05 | 82 | 101 | 6 | M27250 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 3.93e-05 | 88 | 101 | 6 | M16004 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 5.39e-05 | 136 | 101 | 7 | M42547 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 5.65e-05 | 11 | 101 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 5.65e-05 | 11 | 101 | 3 | M26913 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 5.70e-05 | 94 | 101 | 6 | MM14515 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.04e-04 | 151 | 101 | 7 | M550 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.53e-04 | 71 | 101 | 5 | M39690 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | PSMA4 RGPD1 COX6C HMOX2 NUP35 STIP1 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 2.58e-04 | 505 | 101 | 12 | MM15548 |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 2.69e-04 | 18 | 101 | 3 | MM15964 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 4.67e-04 | 138 | 101 | 6 | MM15635 | |
| Pathway | WP_TNFALPHA_SIGNALING | 5.13e-04 | 92 | 101 | 5 | M39662 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 6.40e-04 | 55 | 101 | 4 | MM15137 | |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 6.85e-04 | 56 | 101 | 4 | M13968 | |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 6.85e-04 | 56 | 101 | 4 | MM1406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 7.32e-04 | 25 | 101 | 3 | M47948 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 7.62e-04 | 273 | 101 | 8 | M983 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 9.47e-04 | 61 | 101 | 4 | MM15071 | |
| Pubmed | EZR GAMT IFT81 ZMYND8 MYRIP CCT2 RIPK4 VPS26A CAMK1 HMOX2 APOE CREBBP CHUK USP8 PARP1 FRY ARHGEF10 CHD6 RAPGEF2 HSPA1A HECTD1 HSPA1B HSPA2 HSPA5 HSP90AA1 SH3BP5 KLHL4 | 2.51e-13 | 1285 | 130 | 27 | 35914814 | |
| Pubmed | Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. | 4.96e-13 | 54 | 130 | 9 | 31792442 | |
| Pubmed | 1.70e-11 | 51 | 130 | 8 | 36896912 | ||
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 1.89e-11 | 16 | 130 | 6 | 21738476 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 3.75e-11 | 8 | 130 | 5 | 9122205 | |
| Pubmed | 7.64e-11 | 61 | 130 | 8 | 19875381 | ||
| Pubmed | 8.41e-11 | 9 | 130 | 5 | 21763498 | ||
| Pubmed | EZR EFCAB5 IFT81 RGPD1 COX6C MYRIP TSC1 CCT2 HMOX2 SRCAP ECE1 KRT79 NUP35 CHUK USP8 PARP1 TNRC18 VPS13A CHD6 RIMS2 HSPA2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 1.32e-10 | 1442 | 130 | 25 | 35575683 | |
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 1.68e-10 | 10 | 130 | 5 | 11932435 | |
| Pubmed | 1.68e-10 | 10 | 130 | 5 | 12832005 | ||
| Pubmed | 1.68e-10 | 10 | 130 | 5 | 7906708 | ||
| Pubmed | 1.68e-10 | 10 | 130 | 5 | 23921388 | ||
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 1.86e-10 | 4 | 130 | 4 | 22956628 | |
| Pubmed | 3.09e-10 | 24 | 130 | 6 | 10617616 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EZR ZMYND8 CCT2 SRCAP PARP1 KARS1 ZNF638 SCAF11 STIP1 HSPA1A HSPA5 HSPA8 HSP90AA1 | 4.16e-10 | 332 | 130 | 13 | 32786267 |
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 5.24e-10 | 12 | 130 | 5 | 19275587 | |
| Pubmed | CACNA1A CACNB2 CAD TTC21A COX6C TSC1 CCT2 APOE OLA1 KRT79 ITPR2 PARP1 KARS1 GRK2 ARHGAP44 STIP1 RAPGEF2 HSPA1A HSPA1B HSPA2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 6.33e-10 | 1431 | 130 | 24 | 37142655 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 9.29e-10 | 5 | 130 | 4 | 16906134 | |
| Pubmed | 1.07e-09 | 29 | 130 | 6 | 21532586 | ||
| Pubmed | CAD DSC3 IFT81 APAF1 ASCC1 COX6C HMOX2 CDKAL1 ITPR2 PARP1 MTX2 ABCB10 ARHGEF10 SLC25A15 VPS13A STIP1 SEMA6A HSPA1A HSPA1B HSPA2 HSPA5 AP3D1 HSPA8 EDRF1 | 1.35e-09 | 1487 | 130 | 24 | 33957083 | |
| Pubmed | 1.97e-09 | 15 | 130 | 5 | 10964507 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EZR PRPF31 CAD PSMA4 TSC1 CCT2 OLA1 KRT79 USP8 PARP1 KARS1 RBM19 ZNF638 SCAF11 STIP1 DDX41 HSPA1A HECTD1 EIF2AK2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 2.74e-09 | 1415 | 130 | 23 | 28515276 |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 2.78e-09 | 6 | 130 | 4 | 15963462 | |
| Pubmed | 2.78e-09 | 6 | 130 | 4 | 16397188 | ||
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 2.78e-09 | 6 | 130 | 4 | 7988674 | |
| Pubmed | CAD VPS13C SLC6A17 VPS26A ECE1 CREBBP ESYT3 USP8 PARP1 KARS1 SLC25A15 ZNF638 SV2C CHD6 MED23 RIMS2 HSPA1A | 3.60e-09 | 754 | 130 | 17 | 35906200 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PRPF31 CAD PSMA4 ZMYND8 CCT2 VPS26A ERI1 CDKAL1 PARP1 KARS1 ABCB10 SLC25A15 BRD9 STIP1 CHD6 DDX41 HSPA1A EIF2AK2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 3.93e-09 | 1318 | 130 | 22 | 30463901 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 EHBP1 CACNB2 CACNB3 MCM8 VPS13C WWP1 TTC21A MYRIP CREBBP ADCY3 SBNO2 ARFGEF3 TNRC18 GRK3 SCARB1 ARHGAP44 ZNF638 SCAF11 CHD6 SEMA6A RAPGEF2 HECTD1 | 7.13e-09 | 1489 | 130 | 23 | 28611215 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | PRPF31 ASCC1 CCT2 ERI1 OLA1 XRCC4 CDKAL1 PARP1 KARS1 STIP1 DDX41 HSPA1A EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 9.62e-09 | 704 | 130 | 16 | 32994395 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 EZR CACNB2 CAD PSMA4 CCT2 OLA1 SRCAP KRT79 PARP1 STIP1 HSPA1B HSPA2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 9.81e-09 | 807 | 130 | 17 | 30575818 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | CAD CCT2 VPS26A CREBBP PARP1 GRK2 GRK3 HECTD1 EIF2AK2 HSPA5 HSPA8 HSP90AA1 CDK3 | 9.84e-09 | 432 | 130 | 13 | 23455922 |
| Pubmed | 1.29e-08 | 8 | 130 | 4 | 23482560 | ||
| Pubmed | 1.29e-08 | 8 | 130 | 4 | 25202009 | ||
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 1.39e-08 | 166 | 130 | 9 | 35687106 | |
| Pubmed | DOCK2 EZR CAD HMOX2 APOE OLA1 ECE1 ADCY3 CDKAL1 ITPR2 PARP1 GRK2 RBM19 DDX41 HSPA2 EIF2AK2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 1.43e-08 | 1168 | 130 | 20 | 19946888 | |
| Pubmed | EZR CAD WWP1 CCT2 OLA1 PARP1 GRK2 STIP1 HSPA1A HSPA1B HSPA5 HSPA8 HSP90AA1 | 1.63e-08 | 451 | 130 | 13 | 36168627 | |
| Pubmed | 2.31e-08 | 9 | 130 | 4 | 8486356 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | PRPF31 CAD DSC3 PSMA4 COL6A5 CCT2 POF1B PARP1 KARS1 OTULIN HSPA1B HSPA5 HSPA8 HSP90AA1 | 2.54e-08 | 558 | 130 | 14 | 27591049 |
| Pubmed | 3.38e-08 | 25 | 130 | 5 | 27483141 | ||
| Pubmed | 3.85e-08 | 10 | 130 | 4 | 19171884 | ||
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | CAD PSMA4 CCT2 KARS1 OTULIN DDX41 HSPA1A HSPA1B HSPA8 HSP90AA1 | 4.81e-08 | 256 | 130 | 10 | 35777956 |
| Pubmed | Hsp72 inhibits apoptosis upstream of the mitochondria and not through interactions with Apaf-1. | 5.10e-08 | 3 | 130 | 3 | 15371421 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 23352621 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 24736948 | ||
| Pubmed | Heat shock proteins HSP90, HSP70 and GRP78 expression in medullary thyroid carcinoma. | 5.10e-08 | 3 | 130 | 3 | 28038712 | |
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 5.10e-08 | 3 | 130 | 3 | 15129916 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 21373891 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 36246562 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 28025138 | ||
| Pubmed | 5.83e-08 | 92 | 130 | 7 | 23055941 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 6.03e-08 | 11 | 130 | 4 | 27708256 | |
| Pubmed | 6.28e-08 | 93 | 130 | 7 | 22079093 | ||
| Pubmed | DAB2IP CAD DSC3 TSC1 CCT2 SIX4 ITPR2 POSTN PARP1 TDRD3 KARS1 VPS13A ZNF638 STIP1 HSPA2 HSPA5 PLK4 HSP90AA1 | 7.87e-08 | 1049 | 130 | 18 | 27880917 | |
| Pubmed | 7.95e-08 | 145 | 130 | 8 | 23349634 | ||
| Pubmed | AMBRA1 interplay with cullin E3 ubiquitin ligases regulates autophagy dynamics. | 8.38e-08 | 58 | 130 | 6 | 25499913 | |
| Pubmed | 8.93e-08 | 30 | 130 | 5 | 25864199 | ||
| Pubmed | 9.01e-08 | 12 | 130 | 4 | 23569248 | ||
| Pubmed | 9.30e-08 | 59 | 130 | 6 | 32382008 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP SECISBP2L EHBP1 EZR PRPF31 TTC21A IFT81 COX6C OLA1 XRCC4 CREBBP POSTN USP8 KARS1 ARHGAP44 ZNF638 RPGR DDX41 HSPA5 EDRF1 | 1.07e-07 | 1321 | 130 | 20 | 27173435 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MROH9 VPS13C TTC21A ITPR2 TDRD3 FRY SLC38A10 SAMD9L KARS1 VPS13A STIP1 CHD6 SAMD3 HSPA5 HSPA8 | 1.18e-07 | 736 | 130 | 15 | 29676528 |
| Pubmed | Identification of Redox and Glucose-Dependent Txnip Protein Interactions. | 1.25e-07 | 32 | 130 | 5 | 27437069 | |
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 1.30e-07 | 13 | 130 | 4 | 27477512 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | PSMA4 CCT2 KRT79 PARP1 STIP1 HSPA1A HSPA2 HSPA5 HSPA8 HSP90AA1 | 1.44e-07 | 288 | 130 | 10 | 31501420 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PRPF31 CAD DSC3 PSMA4 TSC1 CCT2 VPS26A ERI1 SRCAP CREBBP PARP1 KARS1 RBM19 ZNF638 DDX41 EIF2AK2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 1.56e-07 | 1353 | 130 | 20 | 29467282 |
| Pubmed | Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. | 2.00e-07 | 35 | 130 | 5 | 19287380 | |
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 23065523 | ||
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 10934467 | ||
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 2.04e-07 | 4 | 130 | 3 | 18299791 | |
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 20806039 | ||
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 18379898 | ||
| Pubmed | Variations in HSP70 genes associated with noise-induced hearing loss in two independent populations. | 2.04e-07 | 4 | 130 | 3 | 18813331 | |
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 10786835 | ||
| Pubmed | HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study. | 2.04e-07 | 4 | 130 | 3 | 23065205 | |
| Pubmed | DOCK2 EZR CAD PSMA4 CCT2 APOE OLA1 SCARB1 HSPA1A HSPA1B HSPA5 HSPA8 HSP90AA1 | 2.22e-07 | 565 | 130 | 13 | 20458337 | |
| Pubmed | 2.32e-07 | 36 | 130 | 5 | 31669268 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EZR PRPF31 CAD DSC3 ASCC1 CCT2 KRT79 ITPR2 PARP1 KARS1 RBM19 ZNF638 SCAF11 DDX41 HSPA1B EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 2.35e-07 | 1257 | 130 | 19 | 36526897 |
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 3.37e-07 | 73 | 130 | 6 | 32347575 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | PRPF31 PSMA4 PARP1 KARS1 DDX41 HSPA1B EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 3.39e-07 | 316 | 130 | 10 | 31665637 |
| Pubmed | EZR CAD VPS13C PSMA4 TSC1 CCT2 VPS26A OLA1 PARP1 STIP1 HSPA1A EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 3.59e-07 | 803 | 130 | 15 | 36517590 | |
| Pubmed | 4.27e-07 | 17 | 130 | 4 | 16275660 | ||
| Pubmed | CAD ASCC1 TSC1 CCT2 POF1B KARS1 ARHGEF10 SCAF11 DDX41 HSPA1A EIF2AK2 AP3D1 HSPA8 | 4.45e-07 | 601 | 130 | 13 | 33658012 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 PSMA4 ZMYND8 TSC1 CCT2 SRCAP USP8 PARP1 TDRD3 KARS1 ZNF638 STIP1 HSPA1A AP3D1 HSPA8 HSP90AA1 | 4.50e-07 | 934 | 130 | 16 | 33916271 |
| Pubmed | EHBP1 EZR CAD DSC3 PSMA4 CCT2 CDKAL1 PARP1 STIP1 HSPA1B HSPA5 AP3D1 HSPA8 HSP90AA1 | 4.60e-07 | 708 | 130 | 14 | 39231216 | |
| Pubmed | 4.63e-07 | 327 | 130 | 10 | 34428256 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | PRPF31 ZMYND8 POF1B PARP1 RBM19 ZNF638 SCAF11 DDX41 HSPA1A HSPA1B HSPA5 HSPA8 HSP90AA1 | 4.80e-07 | 605 | 130 | 13 | 28977666 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | EZR DSC3 WWP1 PSMA4 VPS26A HMOX2 ECE1 USP8 ABCB10 SCARB1 VPS13A STIP1 EPN1 HSPA1A HSPA2 HSPA5 HSPA8 | 4.85e-07 | 1061 | 130 | 17 | 33845483 |
| Pubmed | 5.00e-07 | 78 | 130 | 6 | 27114451 | ||
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 5.08e-07 | 5 | 130 | 3 | 11584023 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 11568360 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 9148915 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 14766729 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 16787652 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 17182002 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 20930503 | ||
| Pubmed | 5.41e-07 | 255 | 130 | 9 | 15324660 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 5.59e-07 | 256 | 130 | 9 | 32698014 | |
| Pubmed | DAB2IP CACNA1A EZR CACNB2 CAD RGPD1 TSC1 PARP1 TDRD3 FRY ARHGAP44 STIP1 RAPGEF2 HSPA8 HSP90AA1 SH3BP5 | 6.73e-07 | 963 | 130 | 16 | 28671696 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 7.77e-07 | 84 | 130 | 6 | 29563501 | |
| Pubmed | 8.19e-07 | 46 | 130 | 5 | 29969578 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 8.19e-07 | 268 | 130 | 9 | 33024031 | |
| Interaction | HSP90AB1 interactions | MTF2 ESRRB TSC1 CCT2 RIPK4 CREBBP CHUK USP8 PARP1 TNRC18 GRK2 VPS13A SCAF11 STIP1 MAPK13 HSPA1A HECTD1 HSPA2 HSPA5 DCAF4 HSPA8 EDRF1 HSP90AA1 CDK3 | 1.03e-08 | 960 | 130 | 24 | int:HSP90AB1 |
| Interaction | DNAJA2 interactions | CAD ESRRB ASCC1 TSC1 RIPK4 PARP1 MTX2 OTULIN BRD9 STIP1 HSPA1A HECTD1 HSPA2 HSPA5 DCAF4 HSPA8 EDRF1 HSP90AA1 | 1.29e-08 | 542 | 130 | 18 | int:DNAJA2 |
| Interaction | CCDC117 interactions | 1.33e-08 | 26 | 130 | 6 | int:CCDC117 | |
| Interaction | EEF1AKMT3 interactions | EHBP1 VPS13C APAF1 CCT2 CAMK1 SIX4 CHUK ARHGEF10 STIP1 HSPA2 EIF2AK2 HSPA5 HSPA8 EDRF1 HSP90AA1 | 1.37e-08 | 364 | 130 | 15 | int:EEF1AKMT3 |
| Interaction | DNAJC7 interactions | CAD VPS13C IFT81 APAF1 RIPK4 TDRD3 VPS13A STIP1 RPGR HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 EDRF1 HSP90AA1 | 1.56e-08 | 425 | 130 | 16 | int:DNAJC7 |
| Interaction | TRIM38 interactions | 2.00e-08 | 47 | 130 | 7 | int:TRIM38 | |
| Interaction | SQSTM1 interactions | PRPF31 CAD TENT4A PSMA4 APAF1 IRF8 CCT2 RIPK4 VPS26A CHUK ARFGEF3 USP8 PARP1 TDRD3 MTX2 GRK2 STIP1 RAPGEF2 MAPK13 EPN1 HECTD1 HSPA1B HSPA5 AP3D1 HSPA8 EDRF1 HSP90AA1 | 2.62e-08 | 1257 | 130 | 27 | int:SQSTM1 |
| Interaction | FBXL4 interactions | 2.83e-08 | 106 | 130 | 9 | int:FBXL4 | |
| Interaction | MAP1B interactions | CACNA1A CAD PSMA4 CCT2 XRCC4 CREBBP KARS1 OTULIN DDX41 HSPA1A HECTD1 HSPA1B HSPA5 PLK4 HSPA8 HSP90AA1 CDK3 | 7.12e-08 | 539 | 130 | 17 | int:MAP1B |
| Interaction | TXNIP interactions | PRPF31 CAD TENT4A WWP1 CCT2 PARP1 STIP1 HSPA1A HSPA1B HSPA8 HSP90AA1 | 1.31e-07 | 212 | 130 | 11 | int:TXNIP |
| Interaction | DNAJB6 interactions | GAMT ESRRB RIPK4 HMOX2 USP8 PARP1 STIP1 HSPA1A HSPA1B HSPA2 HSPA5 DCAF4 HSPA8 HSP90AA1 | 1.65e-07 | 379 | 130 | 14 | int:DNAJB6 |
| Interaction | DNAJA1 interactions | CAD ESRRB TSC1 CCT2 RIPK4 XRCC4 STIP1 RPGR HSPA1A HECTD1 HSPA1B HSPA2 HSPA5 HSPA8 EDRF1 HSP90AA1 | 3.46e-07 | 533 | 130 | 16 | int:DNAJA1 |
| Interaction | CTNNB1 interactions | USP53 EZR CAD DSC3 TSC1 CCT2 APOE CREBBP CHUK USP8 PARP1 ABCA5 STIP1 CHD6 RAPGEF2 HSPA1A HECTD1 HSPA1B HSPA5 DCAF4 HSPA8 HSP90AA1 | 4.87e-07 | 1009 | 130 | 22 | int:CTNNB1 |
| Interaction | DNAJB1 interactions | RIPK4 OLA1 TDRD3 MTX2 OTULIN ARHGEF10 STIP1 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 | 5.15e-07 | 297 | 130 | 12 | int:DNAJB1 |
| Interaction | ARMC5 interactions | CAD RIPK4 PARP1 KARS1 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 7.34e-07 | 201 | 130 | 10 | int:ARMC5 |
| Interaction | DNAJA4 interactions | 7.79e-07 | 79 | 130 | 7 | int:DNAJA4 | |
| Interaction | FBXL15 interactions | 1.08e-06 | 29 | 130 | 5 | int:FBXL15 | |
| Interaction | HSPA4 interactions | EZR PRPF31 APAF1 CCT2 RIPK4 OLA1 PARP1 KARS1 STIP1 HSPA1A HECTD1 HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 CDK3 | 1.40e-06 | 667 | 130 | 17 | int:HSPA4 |
| Interaction | HDAC4 interactions | CACNA1A EZR PSMA4 CAMK1 OLA1 NUP35 PARP1 TDRD3 FRY ZNF638 STIP1 CHD6 RAPGEF2 HSPA1A HSPA5 AP3D1 HSPA8 HSP90AA1 | 1.41e-06 | 744 | 130 | 18 | int:HDAC4 |
| Interaction | MAT2A interactions | PLEKHG7 PSMA4 CCT2 PARP1 KARS1 OTULIN STIP1 HSPA1A HSPA2 HSPA8 | 1.54e-06 | 218 | 130 | 10 | int:MAT2A |
| Interaction | HSP90AA1 interactions | CAD WWP1 TTC21A ESRRB APAF1 TSC1 CCT2 RIPK4 APOE CREBBP CHUK CFLAR GRK2 STIP1 MAPK13 HSPA1A HSPA1B HSPA2 EIF2AK2 HSPA5 HSPA8 EDRF1 HSP90AA1 CDK3 | 1.61e-06 | 1263 | 130 | 24 | int:HSP90AA1 |
| Interaction | PNPLA5 interactions | 2.12e-06 | 33 | 130 | 5 | int:PNPLA5 | |
| Interaction | ALKBH3 interactions | 2.66e-06 | 61 | 130 | 6 | int:ALKBH3 | |
| Interaction | DHFR2 interactions | CAD CCT2 HMOX2 CDKAL1 ITPR2 ARHGEF10 SCARB1 STIP1 HSPA1B HSPA5 HSPA8 | 2.80e-06 | 289 | 130 | 11 | int:DHFR2 |
| Interaction | PHB1 interactions | USP53 EZR CAD PSMA4 ESRRB COX6C CCT2 HMOX2 APOE OLA1 PARP1 KARS1 MTX2 ABCB10 STIP1 MED23 HSPA1A HSPA1B EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 2.86e-06 | 1123 | 130 | 22 | int:PHB1 |
| Interaction | NPHP4 interactions | VPS13C ERI1 STIP1 RPGR HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 KLHL4 | 3.13e-06 | 236 | 130 | 10 | int:NPHP4 |
| Interaction | KLHL34 interactions | 3.23e-06 | 63 | 130 | 6 | int:KLHL34 | |
| Interaction | TRRAP interactions | VPS13C SLC6A17 ESRRB SRCAP ECE1 CREBBP ESYT3 USP8 PARP1 SLC25A15 BRD9 ZNF638 SV2C CHD6 MED23 RIMS2 HSPA1A HECTD1 | 3.27e-06 | 790 | 130 | 18 | int:TRRAP |
| Interaction | CAMKMT interactions | 3.32e-06 | 36 | 130 | 5 | int:CAMKMT | |
| Interaction | FAM83F interactions | 3.32e-06 | 36 | 130 | 5 | int:FAM83F | |
| Interaction | METTL21A interactions | 3.32e-06 | 36 | 130 | 5 | int:METTL21A | |
| Interaction | AGT interactions | 4.37e-06 | 38 | 130 | 5 | int:AGT | |
| Interaction | ST13 interactions | 4.97e-06 | 195 | 130 | 9 | int:ST13 | |
| Interaction | EWSR1 interactions | CAD MTF2 WWP1 PSMA4 ESRRB OLA1 CREBBP PRTFDC1 NUP35 ESYT3 PARP1 TDRD3 ZNF638 STIP1 HSPA1A HSPA2 HSPA5 DCAF4 HSPA8 | 5.65e-06 | 906 | 130 | 19 | int:EWSR1 |
| Interaction | ARAF interactions | CAD TSC1 CCT2 RIPK4 CAMK1 PARP1 CHD6 HSPA1A HECTD1 HSPA5 HSPA8 HSP90AA1 | 5.96e-06 | 376 | 130 | 12 | int:ARAF |
| Interaction | AIMP2 interactions | CAD PSMA4 CCT2 PARP1 KARS1 STIP1 HSPA1A HECTD1 HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 6.41e-06 | 446 | 130 | 13 | int:AIMP2 |
| Interaction | SUMO2 interactions | EZR CAD ZMYND8 CCT2 SRCAP PARP1 KARS1 ZNF638 SCAF11 STIP1 HSPA1A EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 6.45e-06 | 591 | 130 | 15 | int:SUMO2 |
| Interaction | SIN3A interactions | MTF2 XRCC4 CREBBP PARP1 STIP1 DDX41 HSPA1A HECTD1 HSPA5 DCAF4 HSPA8 HSP90AA1 | 6.64e-06 | 380 | 130 | 12 | int:SIN3A |
| Interaction | HSPH1 interactions | EZR CAD CCT2 ZNF638 STIP1 HSPA1A HECTD1 HSPA1B HSPA2 HSPA5 PLK4 HSPA8 HSP90AA1 | 6.73e-06 | 448 | 130 | 13 | int:HSPH1 |
| Interaction | STIP1 interactions | EZR CAD CCT2 RIPK4 OLA1 PARP1 TDRD3 KARS1 ARHGEF10 STIP1 DDX41 HSPA1A HECTD1 HSPA1B HSPA2 HSPA5 AP3D1 HSPA8 HSP90AA1 CDK3 | 6.91e-06 | 1006 | 130 | 20 | int:STIP1 |
| Interaction | TUBG1 interactions | CAD CCT2 OLA1 PARP1 SCAF11 STIP1 RPGR DDX41 HSPA1A HSPA5 HSPA8 HSP90AA1 | 7.00e-06 | 382 | 130 | 12 | int:TUBG1 |
| Interaction | ASH2L interactions | PRPF31 WWP1 ESRRB SRCAP PARP1 HSPA1B HSPA5 DCAF4 HSPA8 HSP90AA1 | 8.71e-06 | 265 | 130 | 10 | int:ASH2L |
| Interaction | BGLT3 interactions | 8.97e-06 | 75 | 130 | 6 | int:BGLT3 | |
| Interaction | STUB1 interactions | CAD PSMA4 RIPK4 OLA1 ADCY3 CHUK CFLAR PARP1 TDRD3 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 HSP90AA1 | 9.05e-06 | 608 | 130 | 15 | int:STUB1 |
| Interaction | SLC12A3 interactions | 9.09e-06 | 21 | 130 | 4 | int:SLC12A3 | |
| Interaction | DNAJB5 interactions | 9.17e-06 | 114 | 130 | 7 | int:DNAJB5 | |
| Interaction | CDK20 interactions | 9.17e-06 | 114 | 130 | 7 | int:CDK20 | |
| Interaction | NR2C2 interactions | PRPF31 CAD PSMA4 ZMYND8 IRF8 CCT2 VPS26A ERI1 CDKAL1 CHUK PARP1 KARS1 ABCB10 SLC25A15 BRD9 STIP1 CHD6 DDX41 HSPA1A EIF2AK2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 9.72e-06 | 1403 | 130 | 24 | int:NR2C2 |
| Interaction | FBXW7 interactions | DAB2IP CAD PSMA4 ZMYND8 ASCC1 TSC1 CCT2 XRCC4 POF1B KARS1 ARHGEF10 BRD9 SCAF11 CHD6 MED23 DDX41 HSPA1A HECTD1 EIF2AK2 AP3D1 HSPA8 HSP90AA1 | 1.00e-05 | 1215 | 130 | 22 | int:FBXW7 |
| Interaction | TSSK6 interactions | 1.28e-05 | 47 | 130 | 5 | int:TSSK6 | |
| Interaction | MAP2K2 interactions | VPS13C OTULIN STIP1 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 EDRF1 HSP90AA1 | 1.32e-05 | 278 | 130 | 10 | int:MAP2K2 |
| Interaction | COPS6 interactions | EHBP1 IRF8 HMOX2 RPGR HSPA1A HSPA1B HSPA5 DCAF4 HSPA8 HSP90AA1 CDK3 KLHL4 | 1.35e-05 | 408 | 130 | 12 | int:COPS6 |
| Interaction | TRIM7 interactions | 1.40e-05 | 81 | 130 | 6 | int:TRIM7 | |
| Interaction | RAB7A interactions | SECISBP2L VPS13C TSC1 VPS26A HMOX2 APOE ECE1 CDKAL1 NUP35 ITPR2 ARFGEF3 SCARB1 VPS13A STIP1 HSPA1A HSPA2 HSPA5 HSPA8 | 1.57e-05 | 886 | 130 | 18 | int:RAB7A |
| Interaction | SND1 interactions | WWP1 CREBBP PARP1 TDRD3 SCAF11 STIP1 RAPGEF2 HSPA1A HECTD1 HSPA8 HSP90AA1 | 1.58e-05 | 347 | 130 | 11 | int:SND1 |
| Interaction | ARHGAP24 interactions | EZR CAD WWP1 CCT2 OLA1 PARP1 GRK2 STIP1 HSPA1A HSPA1B HSPA5 HSPA8 HSP90AA1 | 1.60e-05 | 486 | 130 | 13 | int:ARHGAP24 |
| Interaction | PPP6C interactions | 1.74e-05 | 228 | 130 | 9 | int:PPP6C | |
| Interaction | ALDH3B2 interactions | 1.88e-05 | 25 | 130 | 4 | int:ALDH3B2 | |
| Interaction | TXNDC5 interactions | 1.93e-05 | 231 | 130 | 9 | int:TXNDC5 | |
| Interaction | TUBB interactions | CAD MCM8 PLEKHG7 ESRRB CCT2 RIPK4 OLA1 CREBBP PARP1 STIP1 RPGR HSPA1A HSPA2 HSPA5 HSPA8 HSP90AA1 | 2.11e-05 | 735 | 130 | 16 | int:TUBB |
| Interaction | ZC3H7B interactions | 2.11e-05 | 52 | 130 | 5 | int:ZC3H7B | |
| Interaction | CDK7 interactions | MORC1 PRPF31 PLEKHG7 IFT81 PSMA4 CCT2 CREBBP ABCA5 SLC25A15 HSPA1B HSPA5 HSPA8 HSP90AA1 | 2.20e-05 | 501 | 130 | 13 | int:CDK7 |
| Interaction | METTL22 interactions | 2.21e-05 | 26 | 130 | 4 | int:METTL22 | |
| Interaction | MLF2 interactions | 2.27e-05 | 131 | 130 | 7 | int:MLF2 | |
| Interaction | ZBTB18 interactions | 2.31e-05 | 53 | 130 | 5 | int:ZBTB18 | |
| Interaction | BMX interactions | 2.56e-05 | 90 | 130 | 6 | int:BMX | |
| Interaction | DYRK1B interactions | 2.73e-05 | 91 | 130 | 6 | int:DYRK1B | |
| Interaction | TLE2 interactions | 2.89e-05 | 136 | 130 | 7 | int:TLE2 | |
| Interaction | AGR2 interactions | DOCK2 EZR CACNB2 CAD PSMA4 CCT2 OLA1 SRCAP KRT79 PARP1 STIP1 HSPA1B CDKN2AIPNL HSPA2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 3.15e-05 | 934 | 130 | 18 | int:AGR2 |
| Interaction | PARP1 interactions | MORC1 PRPF31 MTF2 OLA1 XRCC4 SRCAP CREBBP PARP1 RBM19 SLC25A15 SCAF11 STIP1 CHD6 MED23 EPN1 DDX41 HSPA1A HECTD1 HSPA2 HSPA5 AP3D1 HSPA8 | 3.43e-05 | 1316 | 130 | 22 | int:PARP1 |
| Interaction | CDCA5 interactions | 3.48e-05 | 140 | 130 | 7 | int:CDCA5 | |
| Interaction | PRKY interactions | 3.48e-05 | 140 | 130 | 7 | int:PRKY | |
| Interaction | HEY1 interactions | 3.48e-05 | 140 | 130 | 7 | int:HEY1 | |
| Interaction | HSPA4L interactions | 3.60e-05 | 250 | 130 | 9 | int:HSPA4L | |
| Interaction | NCOA2 interactions | 3.65e-05 | 141 | 130 | 7 | int:NCOA2 | |
| Interaction | HNRNPA1 interactions | USP53 PRPF31 CAD WWP1 KRT79 POF1B NUP35 CHUK TDRD3 SAMD9L ZNF638 SCAF11 STIP1 HSPA1A HSPA2 HSPA5 HSPA8 HSP90AA1 | 3.67e-05 | 945 | 130 | 18 | int:HNRNPA1 |
| Interaction | SOX2 interactions | EZR DSC3 PSMA4 ESRRB ZMYND8 CCT2 SIX4 OLA1 POF1B PRTFDC1 ITPR2 PARP1 TNRC18 KARS1 MTX2 ZNF638 STIP1 CHD6 DDX41 EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 3.71e-05 | 1422 | 130 | 23 | int:SOX2 |
| Interaction | LINC01554 interactions | 3.82e-05 | 142 | 130 | 7 | int:LINC01554 | |
| Interaction | AIRE interactions | 3.92e-05 | 97 | 130 | 6 | int:AIRE | |
| Interaction | OGT interactions | PRPF31 ESRRB ASCC1 CCT2 ERI1 OLA1 XRCC4 CREBBP CDKAL1 PARP1 KARS1 STIP1 DDX41 HSPA1A EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 3.93e-05 | 950 | 130 | 18 | int:OGT |
| Interaction | BUB1B interactions | 3.95e-05 | 195 | 130 | 8 | int:BUB1B | |
| Interaction | PAGE4 interactions | 3.95e-05 | 253 | 130 | 9 | int:PAGE4 | |
| Interaction | RAD21 interactions | PRPF31 CAD ESRRB CCT2 OLA1 PARP1 STIP1 HSPA1A HECTD1 HSPA8 HSP90AA1 | 3.99e-05 | 384 | 130 | 11 | int:RAD21 |
| Interaction | CDKN1B interactions | 4.17e-05 | 144 | 130 | 7 | int:CDKN1B | |
| Interaction | CDC73 interactions | CCT2 CHUK PARP1 KARS1 STIP1 HECTD1 HSPA2 HSPA5 AP3D1 HSPA8 HSP90AA1 | 4.19e-05 | 386 | 130 | 11 | int:CDC73 |
| Interaction | PPT1 interactions | 4.33e-05 | 256 | 130 | 9 | int:PPT1 | |
| Interaction | GSK3B interactions | CAD MTF2 RGPD1 TSC1 CCT2 HMOX2 ARFGEF3 PARP1 TDRD3 OTULIN CHD6 HSPA1A HECTD1 HSPA2 HSPA5 HSPA8 HSP90AA1 | 4.36e-05 | 868 | 130 | 17 | int:GSK3B |
| Interaction | EDRF1 interactions | 4.40e-05 | 99 | 130 | 6 | int:EDRF1 | |
| Interaction | CEBPB interactions | DOCK2 EZR CAD IRF8 CCT2 HMOX2 OLA1 XRCC4 CREBBP SBNO2 NUP35 PARP1 KARS1 ZNF638 STIP1 MED23 DDX41 HSPA1A CDKN2AIPNL EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 4.66e-05 | 1443 | 130 | 23 | int:CEBPB |
| Interaction | RUNX1 interactions | 4.87e-05 | 324 | 130 | 10 | int:RUNX1 | |
| Interaction | CUL1 interactions | DAB2IP PSMA4 CCT2 RIPK4 XRCC4 CHUK CFLAR PARP1 KARS1 SCARB1 STIP1 HSPA1A HSPA1B HSPA5 HSPA8 HSP90AA1 CDK3 | 4.89e-05 | 876 | 130 | 17 | int:CUL1 |
| Interaction | BAG2 interactions | VPS13C RIPK4 CREBBP TDRD3 ARHGEF10 STIP1 EPN1 HSPA1A HSPA1B HSPA2 HSPA5 HSPA8 EDRF1 HSP90AA1 | 5.00e-05 | 622 | 130 | 14 | int:BAG2 |
| Interaction | DNAJB2 interactions | 5.21e-05 | 102 | 130 | 6 | int:DNAJB2 | |
| Interaction | AFG2B interactions | 5.50e-05 | 103 | 130 | 6 | int:AFG2B | |
| Interaction | AMBRA1 interactions | 5.66e-05 | 265 | 130 | 9 | int:AMBRA1 | |
| Interaction | LOXL4 interactions | 5.81e-05 | 104 | 130 | 6 | int:LOXL4 | |
| Interaction | VPS41 interactions | 5.81e-05 | 64 | 130 | 5 | int:VPS41 | |
| Interaction | PPP2CB interactions | 5.99e-05 | 267 | 130 | 9 | int:PPP2CB | |
| Interaction | RBM14 interactions | WWP1 OLA1 NUP35 PARP1 ZNF638 STIP1 MED23 HSPA1A HECTD1 HSPA1B HSPA5 DCAF4 HSPA8 | 6.07e-05 | 553 | 130 | 13 | int:RBM14 |
| Interaction | TOMM70 interactions | 6.13e-05 | 153 | 130 | 7 | int:TOMM70 | |
| Cytoband | 2p22-p21 | 2.20e-04 | 8 | 130 | 2 | 2p22-p21 | |
| GeneFamily | Heat shock 70kDa proteins | 1.71e-08 | 17 | 91 | 5 | 583 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.95e-04 | 26 | 91 | 3 | 253 | |
| GeneFamily | Maestro heat like repeat containing | 1.34e-03 | 11 | 91 | 2 | 636 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | VPS13C WWP1 PSMA4 VPS26A XRCC4 ITPR2 USP8 TDRD3 ABCA5 ARHGAP44 ZNF638 SCAF11 RPGR HECTD1 HSP90AA1 | 9.58e-07 | 656 | 130 | 15 | M18979 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_BASAL_EPITHELIAL_CELL_OF_TRACHEOBRONCHIAL_TREE_AGEING | 3.94e-06 | 22 | 130 | 4 | MM3854 | |
| Coexpression | FISCHER_DREAM_TARGETS | USP53 EHBP1 CAD MCM8 MTF2 ERI1 XRCC4 KIF24 CDKAL1 NUP35 CFLAR ABCB10 STIP1 CDKN2AIPNL PLK4 HSPA8 HSP90AA1 | 6.31e-06 | 969 | 130 | 17 | M149 |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN | 7.06e-06 | 199 | 130 | 8 | M3594 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 7.06e-06 | 199 | 130 | 8 | M5230 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP | 7.32e-06 | 200 | 130 | 8 | M6668 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 7.94e-06 | 26 | 130 | 4 | M1380 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | CACNA1A SERHL2 PRPF31 CACNB2 CACNB3 RIPK4 CAMK1 HMOX2 APOE SRCAP ADCY3 CFLAR SCARB1 EPN1 DCAF4 CDK3 | 1.16e-05 | 909 | 130 | 16 | M41018 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | CACNB2 WWP1 VPS26A CFLAR POSTN PARP1 FRY MTX2 HSPA2 HSPA5 HSP90AA1 | 1.20e-05 | 437 | 130 | 11 | M4665 |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 1.39e-05 | 10 | 130 | 3 | MM1243 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | TENT4A ZMYND8 CREBBP VPS13A ZNF638 SCAF11 RAPGEF2 PLK4 EDRF1 | 1.96e-05 | 300 | 130 | 9 | M8702 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | WWP1 PSMA4 CCT2 CREBBP CFLAR PARP1 SCAF11 HSPA1A EIF2AK2 HSPA5 AP3D1 HSPA8 | 2.71e-05 | 568 | 130 | 12 | M4023 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 3.45e-05 | 181 | 130 | 7 | M39225 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | 5.09e-05 | 262 | 130 | 8 | M11472 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 5.71e-05 | 196 | 130 | 7 | MM3746 | |
| Coexpression | GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 5.90e-05 | 197 | 130 | 7 | M7560 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 5.96e-05 | 268 | 130 | 8 | M45696 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 6.09e-05 | 198 | 130 | 7 | M3171 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN | 6.29e-05 | 199 | 130 | 7 | M3588 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 6.41e-05 | 137 | 130 | 6 | MM16612 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP | 6.49e-05 | 200 | 130 | 7 | M8564 | |
| Coexpression | COLLIS_PRKDC_SUBSTRATES | 7.70e-05 | 17 | 130 | 3 | M4495 | |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_UP | 7.83e-05 | 88 | 130 | 5 | M9869 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | 8.50e-05 | 282 | 130 | 8 | MM3642 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_LB_UP | 8.73e-05 | 47 | 130 | 4 | M14744 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L EHBP1 MTF2 WWP1 ZMYND8 XRCC4 CREBBP TDRD3 MTX2 ARHGEF10 VPS13A ZNF638 RPGR RAPGEF2 | 9.28e-05 | 856 | 130 | 14 | M4500 |
| Coexpression | AIZARANI_LIVER_C12_NK_NKT_CELLS_4 | 1.03e-04 | 49 | 130 | 4 | M39116 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 1.14e-04 | 152 | 130 | 6 | M39239 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 1.14e-04 | 152 | 130 | 6 | M2964 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | EHBP1 MTF2 ZMYND8 XRCC4 CREBBP MTX2 VPS13A ZNF638 RPGR RAPGEF2 | 1.14e-04 | 466 | 130 | 10 | M13522 |
| Coexpression | KIM_WT1_TARGETS_DN | PRPF31 VPS13C ZMYND8 APAF1 APOE STIP1 RAPGEF2 HSPA1A HSPA1B HSPA5 | 1.25e-04 | 471 | 130 | 10 | M17859 |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 1.30e-04 | 98 | 130 | 5 | M40018 | |
| Coexpression | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN | 1.71e-04 | 22 | 130 | 3 | M1191 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 1.74e-04 | 313 | 130 | 8 | M40228 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 1.94e-04 | 318 | 130 | 8 | M41707 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.03e-04 | 169 | 130 | 6 | M39230 | |
| Coexpression | MA_RAT_AGING_DN | 2.09e-04 | 170 | 130 | 6 | MM16097 | |
| Coexpression | JIANG_MELANOMA_TRM1_CD8 | 2.60e-04 | 177 | 130 | 6 | M48965 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.60e-04 | 177 | 130 | 6 | M39245 | |
| Coexpression | FAN_OVARY_CL18_B_LYMPHOCYTE | 2.64e-04 | 422 | 130 | 9 | M41720 | |
| Coexpression | PEREZ_TP53_TARGETS | DAB2IP CACNB2 CACNB3 GAMT VPS13C MROH2A APAF1 RIPK4 CAMK1 ECE1 CFLAR FRY GRK3 ARHGAP44 MED23 MAPK13 | 3.05e-04 | 1201 | 130 | 16 | M4391 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SECISBP2L CREBBP ARFGEF3 CFLAR FRY ABCA5 VPS13A RAPGEF2 MED23 HSPA1A HSPA1B HSP90AA1 SH3BP5 | 3.34e-04 | 854 | 130 | 13 | M1533 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SECISBP2L MTF2 ZMYND8 APAF1 TSC1 CCT2 XRCC4 ITPR2 TDRD3 KARS1 MTX2 GRK3 RAPGEF2 HSPA5 PLK4 EDRF1 | 3.47e-04 | 1215 | 130 | 16 | M41122 |
| Coexpression | ZIRN_TRETINOIN_RESPONSE_WT1_DN | 3.61e-04 | 6 | 130 | 2 | M7641 | |
| Coexpression | FAN_EMBRYONIC_CTX_IN_6_INTERNEURON | 3.61e-04 | 6 | 130 | 2 | M39032 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS | 4.13e-04 | 356 | 130 | 8 | M43609 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | CAD MTF2 PSMA4 COX6C CCT2 CHUK PARP1 KARS1 MTX2 PLK4 HSPA8 HSP90AA1 | 4.16e-04 | 761 | 130 | 12 | M11961 |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN | 4.48e-04 | 196 | 130 | 6 | M4973 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 4.67e-04 | 276 | 130 | 7 | M3063 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN | 4.73e-04 | 198 | 130 | 6 | M6068 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SECISBP2L CREBBP ARFGEF3 CFLAR FRY ABCA5 VPS13A RAPGEF2 MED23 HSPA1A HSPA1B HSP90AA1 SH3BP5 | 4.83e-04 | 888 | 130 | 13 | MM1018 |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN | 4.85e-04 | 199 | 130 | 6 | M3591 | |
| Coexpression | CAMP_UP.V1_DN | 4.85e-04 | 199 | 130 | 6 | M2719 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN | 4.85e-04 | 199 | 130 | 6 | M7291 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN | 4.85e-04 | 199 | 130 | 6 | M5219 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP | 4.85e-04 | 199 | 130 | 6 | M4271 | |
| Coexpression | GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP | 4.98e-04 | 200 | 130 | 6 | M8099 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 4.98e-04 | 200 | 130 | 6 | M3279 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN | 4.98e-04 | 200 | 130 | 6 | M3237 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP | 4.98e-04 | 200 | 130 | 6 | M3459 | |
| Coexpression | GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN | 4.98e-04 | 200 | 130 | 6 | M8602 | |
| Coexpression | GSE17721_LPS_VS_CPG_1H_BMDC_DN | 4.98e-04 | 200 | 130 | 6 | M3987 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 4.98e-04 | 200 | 130 | 6 | M8975 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 4.98e-04 | 200 | 130 | 6 | M5566 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP | 4.98e-04 | 200 | 130 | 6 | M9235 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_DN | 4.98e-04 | 200 | 130 | 6 | M3165 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 4.98e-04 | 200 | 130 | 6 | M3188 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN | 5.31e-04 | 282 | 130 | 7 | M7623 | |
| Coexpression | NOJIMA_SFRP2_TARGETS_UP | 5.32e-04 | 32 | 130 | 3 | M14772 | |
| Coexpression | KASLER_HDAC7_TARGETS_2_DN | 5.32e-04 | 32 | 130 | 3 | MM913 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA | 5.42e-04 | 371 | 130 | 8 | M39022 | |
| Coexpression | WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN | 5.42e-04 | 371 | 130 | 8 | M2132 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | PLEKHG7 TTC21A SAMD9L STIP1 HSPA1A HSPA1B EIF2AK2 HSPA8 HSP90AA1 | 2.83e-09 | 178 | 130 | 9 | ef6111238703579a34bd6948bd9d4ca6b7e16063 |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 5.28e-08 | 177 | 130 | 8 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-08 | 191 | 130 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-08 | 191 | 130 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-08 | 192 | 130 | 8 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.44e-07 | 175 | 130 | 7 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 9.10e-07 | 177 | 130 | 7 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-07 | 178 | 130 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.14e-06 | 183 | 130 | 7 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-06 | 185 | 130 | 7 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 185 | 130 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-06 | 186 | 130 | 7 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 191 | 130 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.57e-06 | 192 | 130 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.62e-06 | 193 | 130 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 195 | 130 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-06 | 196 | 130 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-06 | 196 | 130 | 7 | d79a84aa25ba70483ae899cd5b52ba0bbffdcd7b | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.92e-06 | 198 | 130 | 7 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-06 | 198 | 130 | 7 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | mLN-B_cell-B_cell_memory|B_cell / Region, Cell class and subclass | 1.92e-06 | 198 | 130 | 7 | e2c63ca9f82f8524447e398b11a676b22d2f58ce | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-06 | 198 | 130 | 7 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.99e-06 | 199 | 130 | 7 | 0d1f2b0d10c1f8ee10c448659b2a22ea0a6a6f0d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.99e-06 | 199 | 130 | 7 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.99e-06 | 199 | 130 | 7 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 171 | 130 | 6 | a474aaed3ca4cacb0ab565c35f25d92a10f531b7 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 171 | 130 | 6 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 172 | 130 | 6 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 174 | 130 | 6 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-05 | 177 | 130 | 6 | 9edfb50856f5e10672ab194ce0076d6a190e64de | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-05 | 179 | 130 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 180 | 130 | 6 | b83d067dee641941c596e4a25d81327931b6ad61 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 182 | 130 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 182 | 130 | 6 | 9174fb0b7ed8f721a5c513e41fd80476a9f34332 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 184 | 130 | 6 | 1e6f86f9e379cd9f453f6b7185f681b44eb63e09 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 1.74e-05 | 185 | 130 | 6 | b8cd94cf18308b514fc61557550225794ffd2860 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 187 | 130 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-05 | 188 | 130 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.97e-05 | 189 | 130 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.97e-05 | 189 | 130 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 189 | 130 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.97e-05 | 189 | 130 | 6 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.02e-05 | 190 | 130 | 6 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.02e-05 | 190 | 130 | 6 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.02e-05 | 190 | 130 | 6 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|B_lymphocytes / Location, Cell class and cell subclass | 2.02e-05 | 190 | 130 | 6 | c5c80a6b9087821a2e07250fa90bcd3505f103b6 | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 191 | 130 | 6 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.13e-05 | 114 | 130 | 5 | f48fd7d378626eb7ef972ff1df87dd6149cb355c | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.15e-05 | 192 | 130 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-05 | 192 | 130 | 6 | 7197e401e563441ab94815f7619e032ebef9e586 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-05 | 193 | 130 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.21e-05 | 193 | 130 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.21e-05 | 193 | 130 | 6 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-05 | 194 | 130 | 6 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.34e-05 | 195 | 130 | 6 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-05 | 196 | 130 | 6 | a53caedd0103bd162b3aee8ab87b4442a5e0338f | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 197 | 130 | 6 | cd54e6ad175529327fa0372033016b3b978dd452 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 197 | 130 | 6 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 197 | 130 | 6 | 0b2ad6a933ff1a325649cc8f139380fd158a1d42 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 197 | 130 | 6 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.48e-05 | 197 | 130 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 198 | 130 | 6 | 64d73804902a043bdf66b413b769e853d111c033 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 130 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | mLN-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 2.55e-05 | 198 | 130 | 6 | 404ec46bd39b6f4d02a03ef38c30850bbbd8b608 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-05 | 198 | 130 | 6 | 294a48ef6c0b89c7be948452cea79d23d3901e75 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 198 | 130 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.55e-05 | 198 | 130 | 6 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-05 | 198 | 130 | 6 | ec115c4a5dbc54206c72140aa0c8d6a7c29c5563 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.55e-05 | 198 | 130 | 6 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | (4)_Endothelial_cells-(4)_Blood_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.63e-05 | 199 | 130 | 6 | e24d70e79f25cdd3300bf5e2322713355264d4c5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.63e-05 | 199 | 130 | 6 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 199 | 130 | 6 | 54b64f01e7a73a88bd92b6d4e73cccde60396b2d | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-05 | 199 | 130 | 6 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 199 | 130 | 6 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 199 | 130 | 6 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 2.70e-05 | 200 | 130 | 6 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | Transverse|World / shred on region, Cell_type, and subtype | 2.70e-05 | 200 | 130 | 6 | 1b4925a17be02f99b69c45f66577986a2dc107fd | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.70e-05 | 200 | 130 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.70e-05 | 200 | 130 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Transverse|World / Region, Cell class and subclass | 2.70e-05 | 200 | 130 | 6 | 9dee983d7e43af8b3fbed795d8432af67b33c3b3 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 3b07cf1a4dff2e868f52382681a2030c1248caed | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|Megakaryo-cells / Lineage, cell class and subclass | 2.70e-05 | 200 | 130 | 6 | f36023bb369d17b8ec8724616737738e3df01987 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.72e-05 | 145 | 130 | 5 | 9743d68ba8bfef56fd9a979ab357c0e287eb5ae2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-04 | 159 | 130 | 5 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 162 | 130 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 162 | 130 | 5 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 165 | 130 | 5 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 165 | 130 | 5 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 167 | 130 | 5 | c2a0fdb35ec48b956be0686534b29164db6638ab | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 167 | 130 | 5 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.40e-05 | 50 | 85 | 5 | GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS | |
| Drug | EGTA-AM | 6.04e-08 | 62 | 129 | 7 | CID000121907 | |
| Drug | Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.07e-07 | 199 | 129 | 10 | 2564_DN | |
| Drug | KNK 437 | 3.15e-07 | 11 | 129 | 4 | ctd:C410027 | |
| Drug | glutamin | CACNA1A CAD WWP1 PSMA4 APAF1 CREBBP CFLAR KARS1 GRK2 STIP1 HSPA2 HSPA5 HSPA8 HSP90AA1 | 3.74e-07 | 461 | 129 | 14 | CID000000738 |
| Drug | DMAB | 9.24e-07 | 133 | 129 | 8 | CID000006053 | |
| Drug | thioflavin T | 1.44e-06 | 141 | 129 | 8 | CID000016953 | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; HL60; HT_HG-U133A | 1.82e-06 | 196 | 129 | 9 | 2196_DN | |
| Drug | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1.85e-06 | 65 | 129 | 6 | ctd:D002259 | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | 1.90e-06 | 197 | 129 | 9 | 4438_UP | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.98e-06 | 198 | 129 | 9 | 4498_UP | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; PC3; HT_HG-U133A | 1.98e-06 | 198 | 129 | 9 | 6351_UP | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; HL60; HT_HG-U133A | 2.06e-06 | 199 | 129 | 9 | 2577_DN | |
| Drug | Apigenin | 2.85e-06 | 207 | 129 | 9 | ctd:D047310 | |
| Drug | formetanate | 3.51e-06 | 6 | 129 | 3 | ctd:C100163 | |
| Drug | pyrazole | 3.60e-06 | 213 | 129 | 9 | ctd:C031280 | |
| Drug | Thiostrepton | 3.88e-06 | 42 | 129 | 5 | ctd:D013883 | |
| Drug | tempol | 4.86e-06 | 221 | 129 | 9 | CID000137994 | |
| Drug | Chrysamine-G | 5.41e-06 | 78 | 129 | 6 | CID005488970 | |
| Drug | pirimicarb | 6.12e-06 | 7 | 129 | 3 | ctd:C011994 | |
| Drug | lithocholyltaurine | 7.18e-06 | 175 | 129 | 8 | CID000010595 | |
| Drug | Spotlight | 7.68e-06 | 126 | 129 | 7 | CID000086222 | |
| Drug | GGMP | 9.75e-06 | 8 | 129 | 3 | CID006443839 | |
| Drug | CTK8G2960 | 1.12e-05 | 186 | 129 | 8 | CID005361912 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.17e-05 | 187 | 129 | 8 | 4302_DN | |
| Drug | GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A | 1.21e-05 | 188 | 129 | 8 | 7097_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 1.21e-05 | 188 | 129 | 8 | 4310_DN | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A | 1.36e-05 | 191 | 129 | 8 | 4247_DN | |
| Drug | NSC71948 | 1.39e-05 | 138 | 129 | 7 | CID000415676 | |
| Drug | LY294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.47e-05 | 193 | 129 | 8 | 5965_DN | |
| Drug | Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.47e-05 | 193 | 129 | 8 | 6207_UP | |
| Drug | Hyaluronic Acid | 1.52e-05 | 194 | 129 | 8 | ctd:D006820 | |
| Drug | Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.52e-05 | 194 | 129 | 8 | 2825_UP | |
| Drug | Monocrotaline [315-22-0]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 7127_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 3530_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 4718_DN | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 3362_DN | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 7287_DN | |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 2970_DN | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 3572_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 3425_DN | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 3186_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 1508_DN | |
| Drug | Lymecycline [992-21-2]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.70e-05 | 197 | 129 | 8 | 3514_DN | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; PC3; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 3997_UP | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 2125_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 2555_DN | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 4428_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 6992_UP | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 3565_DN | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; PC3; HT_HG-U133A | 1.83e-05 | 199 | 129 | 8 | 1808_DN | |
| Drug | formetanate | 2.07e-05 | 10 | 129 | 3 | CID000031099 | |
| Drug | AC1L45LU | 2.26e-05 | 205 | 129 | 8 | CID000151069 | |
| Drug | Bay K 8644 | 2.39e-05 | 150 | 129 | 7 | CID000002303 | |
| Drug | chromomycin A3 | 2.68e-05 | 103 | 129 | 6 | CID000656673 | |
| Drug | bifenthrin | 2.68e-05 | 103 | 129 | 6 | ctd:C099952 | |
| Drug | 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide | 3.19e-05 | 2 | 129 | 2 | ctd:C554680 | |
| Drug | nickel acetate | 3.33e-05 | 107 | 129 | 6 | ctd:C119536 | |
| Drug | calphostin C | CAMK1 APOE ECE1 ADCY3 CHUK KARS1 GRK2 GRK3 RBM19 KCNIP4 MAPK13 | 3.54e-05 | 431 | 129 | 11 | CID000002533 |
| Drug | phorbol acetate myristate | CACNA1A CACNB2 CACNB3 ESRRB CAMK1 HMOX2 APOE CREBBP ADCY3 CHUK CFLAR SAMD9L GRK2 GRK3 RBM19 SCARB1 MAPK13 HSPA2 EIF2AK2 HSPA5 HSPA8 | 3.86e-05 | 1399 | 129 | 21 | CID000004792 |
| Drug | pyrithione zinc | 3.94e-05 | 67 | 129 | 5 | ctd:C010423 | |
| Drug | Cocaine | DAB2IP EZR CACNB3 IFT81 COX6C CCT2 OLA1 CREBBP CFLAR PARP1 GRK2 ABCA5 SCARB1 ARHGAP44 SEMA6A DDX41 HSPA1A HSPA1B HSPA5 HSP90AA1 | 4.98e-05 | 1314 | 129 | 20 | ctd:D003042 |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 5.13e-05 | 169 | 129 | 7 | 1056_UP | |
| Drug | o,p'-DDT | PSMA4 APAF1 CCT2 HMOX2 CREBBP CFLAR PARP1 MAPK13 HSPA2 HSPA8 HSP90AA1 | 5.33e-05 | 451 | 129 | 11 | ctd:C016340 |
| Drug | geldanamicin | APAF1 CHUK CFLAR GRK2 GRK3 STIP1 HSPA2 EIF2AK2 HSPA8 HSP90AA1 | 5.39e-05 | 373 | 129 | 10 | CID000003460 |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 5.73e-05 | 172 | 129 | 7 | 1159_UP | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.73e-05 | 172 | 129 | 7 | 910_UP | |
| Drug | AC1L1KC5 | CACNA1A CACNB2 CACNB3 APAF1 CAMK1 HMOX2 ADCY3 PARP1 GRK2 GRK3 MAPK13 HSPA5 | 6.03e-05 | 541 | 129 | 12 | CID000005428 |
| Drug | AC1L1IZ2 | 6.05e-05 | 304 | 129 | 9 | CID000004795 | |
| Drug | AC1L1K9Q | 6.25e-05 | 38 | 129 | 4 | CID000005399 | |
| Drug | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | EZR MCM8 APAF1 COX6C CCT2 PARP1 SCARB1 RPGR HSPA2 HSPA5 HSPA8 HSP90AA1 | 6.47e-05 | 545 | 129 | 12 | ctd:C049584 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.62e-05 | 176 | 129 | 7 | 6784_DN | |
| Drug | 5-(4-methylpiperazin-1-yl)-2-(2'-(3,4-dimethoxyphenyl)-5'-benzimidazolyl)benzimidazole | 6.94e-05 | 39 | 129 | 4 | ctd:C477187 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 7.11e-05 | 178 | 129 | 7 | 3998_DN | |
| Drug | 3-nitropropionic acid | 7.11e-05 | 178 | 129 | 7 | CID000001678 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 7.37e-05 | 179 | 129 | 7 | 5590_UP | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 7.37e-05 | 179 | 129 | 7 | 6184_UP | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 7.37e-05 | 179 | 129 | 7 | 4585_DN | |
| Drug | SB 203580 | 7.49e-05 | 388 | 129 | 10 | ctd:C093642 | |
| Drug | SNX 2112 | 7.69e-05 | 15 | 129 | 3 | ctd:C534922 | |
| Drug | vorinostat | CACNA1A APAF1 APOE PRTFDC1 CFLAR PARP1 EIF2AK2 HSPA8 HSP90AA1 | 7.76e-05 | 314 | 129 | 9 | CID000005311 |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.90e-05 | 181 | 129 | 7 | 7077_DN | |
| Drug | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | IRF8 CREBBP CFLAR PARP1 SCARB1 PNPLA3 HSPA1A HSPA1B EIF2AK2 HSPA5 HSPA8 HSP90AA1 | 8.10e-05 | 558 | 129 | 12 | ctd:C072553 |
| Drug | Fructose | 8.21e-05 | 246 | 129 | 8 | ctd:D005632 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 8.46e-05 | 183 | 129 | 7 | 7498_DN | |
| Drug | PreView | 8.47e-05 | 41 | 129 | 4 | CID000176144 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 9.06e-05 | 185 | 129 | 7 | 1226_UP | |
| Drug | Mercuric Chloride | EHBP1 PSMA4 IRF8 VPS26A CREBBP PRTFDC1 CHUK ARFGEF3 PARP1 STIP1 RPGR HSPA1A HECTD1 HSPA1B EIF2AK2 HSPA5 PLK4 HSPA8 | 9.16e-05 | 1155 | 129 | 18 | ctd:D008627 |
| Drug | Verapamil | 9.43e-05 | 16 | 129 | 3 | DB00661 | |
| Drug | Glyoxylspermidine | 9.52e-05 | 3 | 129 | 2 | CID000133564 | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.00e-04 | 188 | 129 | 7 | 1865_DN | |
| Drug | Dimethylformamide | 1.02e-04 | 43 | 129 | 4 | ctd:D004126 | |
| Drug | Asbestos, Amphibole | 1.03e-04 | 131 | 129 | 6 | ctd:D017636 | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.04e-04 | 189 | 129 | 7 | 2790_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 190 | 129 | 7 | 2869_DN | |
| Drug | Galactosamine | 1.10e-04 | 83 | 129 | 5 | ctd:D005688 | |
| Drug | flavone | 1.12e-04 | 44 | 129 | 4 | ctd:C043562 | |
| Drug | Methomyl | 1.14e-04 | 17 | 129 | 3 | ctd:D008724 | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.14e-04 | 192 | 129 | 7 | 6254_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.14e-04 | 192 | 129 | 7 | 3929_DN | |
| Drug | gedunin | 1.17e-04 | 84 | 129 | 5 | ctd:C106014 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 8.30e-07 | 5 | 130 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 4.60e-06 | 8 | 130 | 3 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 1.93e-05 | 2 | 130 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 1.93e-05 | 2 | 130 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | EHBP1 TENT4A LEKR1 RGPD1 ERI1 APOE SCGN ECE1 PRTFDC1 ESYT3 SCARB1 BRD9 VPS13A SV2C PNPLA3 EIF2AK2 DCAF4 HSPA8 | 2.65e-05 | 1347 | 130 | 18 | EFO_0005192 |
| Disease | Alzheimer's disease (is_implicated_in) | 2.71e-05 | 132 | 130 | 6 | DOID:10652 (is_implicated_in) | |
| Disease | congestive heart failure (is_marker_for) | 3.19e-05 | 82 | 130 | 5 | DOID:6000 (is_marker_for) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 5.76e-05 | 3 | 130 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 5.76e-05 | 3 | 130 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Arterial Fatty Streak | 1.91e-04 | 5 | 130 | 2 | C0015697 | |
| Disease | Atheroma | 1.91e-04 | 5 | 130 | 2 | C0264956 | |
| Disease | Plaque, Atherosclerotic | 1.91e-04 | 5 | 130 | 2 | C2936350 | |
| Disease | Fibroatheroma | 1.91e-04 | 5 | 130 | 2 | C2936351 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 3.11e-04 | 30 | 130 | 3 | DOID:14330 (biomarker_via_orthology) | |
| Disease | age at menopause | 3.97e-04 | 302 | 130 | 7 | EFO_0004704 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.80e-04 | 152 | 130 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | CACNB2 PLEKHG7 LEKR1 ERI1 APOE KRT79 USP8 SCARB1 ZNF638 KCNIP4 PNPLA3 EIF2AK2 | 6.72e-04 | 904 | 130 | 12 | EFO_0004736 |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 6.80e-04 | 9 | 130 | 2 | C1846707 | |
| Disease | Major depression, single episode | 6.80e-04 | 9 | 130 | 2 | C0024517 | |
| Disease | thoracic aortic calcification measurement | 6.80e-04 | 9 | 130 | 2 | EFO_0010273 | |
| Disease | congestive heart failure (implicated_via_orthology) | 7.88e-04 | 41 | 130 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | Carcinoma, Transitional Cell | 7.88e-04 | 41 | 130 | 3 | C0007138 | |
| Disease | triacylglycerol 56:6 measurement | 9.07e-04 | 43 | 130 | 3 | EFO_0010433 | |
| Disease | amino acid metabolic disorder (is_implicated_in) | 1.03e-03 | 11 | 130 | 2 | DOID:9252 (is_implicated_in) | |
| Disease | frontal fibrosing alopecia | 1.25e-03 | 48 | 130 | 3 | EFO_0009855 | |
| Disease | Skin Abnormalities | 1.46e-03 | 13 | 130 | 2 | C0037268 | |
| Disease | sphingomyelin measurement | 1.49e-03 | 278 | 130 | 6 | EFO_0010118 | |
| Disease | factor VIII measurement, coronary artery disease | 1.60e-03 | 113 | 130 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | body composition measurement | 1.68e-03 | 193 | 130 | 5 | EFO_0005106 | |
| Disease | cholesterol efflux capacity measurement | 1.69e-03 | 14 | 130 | 2 | EFO_0009132 | |
| Disease | Mouth Neoplasms | 1.76e-03 | 54 | 130 | 3 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 1.76e-03 | 54 | 130 | 3 | C0153381 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.95e-03 | 15 | 130 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | infant head circumference | 1.95e-03 | 15 | 130 | 2 | EFO_0004577 | |
| Disease | neurofilament light chain measurement | 2.06e-03 | 57 | 130 | 3 | EFO_0009178 | |
| Disease | low density lipoprotein particle size measurement | 2.16e-03 | 58 | 130 | 3 | EFO_0008593 | |
| Disease | liver fat measurement, liver disease biomarker | 2.22e-03 | 16 | 130 | 2 | EFO_0006845, EFO_0010821 | |
| Disease | atherosclerosis (is_implicated_in) | 2.22e-03 | 16 | 130 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | Squamous cell carcinoma | 2.24e-03 | 124 | 130 | 4 | C0007137 | |
| Disease | multiple myeloma (is_implicated_in) | 2.27e-03 | 59 | 130 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | Atherosclerosis | 2.27e-03 | 59 | 130 | 3 | C0004153 | |
| Disease | colon cancer (is_marker_for) | 2.27e-03 | 59 | 130 | 3 | DOID:219 (is_marker_for) | |
| Disease | Atherogenesis | 2.27e-03 | 59 | 130 | 3 | C1563937 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.51e-03 | 17 | 130 | 2 | EFO_0022232 | |
| Disease | Seizures | 2.85e-03 | 218 | 130 | 5 | C0036572 | |
| Disease | diacylglycerol 38:5 measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0020065 | |
| Disease | Parkinson's disease (is_marker_for) | 3.26e-03 | 67 | 130 | 3 | DOID:14330 (is_marker_for) | |
| Disease | hypertension (biomarker_via_orthology) | 3.39e-03 | 227 | 130 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | rheumatoid arthritis (is_marker_for) | 3.54e-03 | 69 | 130 | 3 | DOID:7148 (is_marker_for) | |
| Disease | saturated fatty acids to total fatty acids percentage | 3.83e-03 | 21 | 130 | 2 | EFO_0022305 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 3.83e-03 | 21 | 130 | 2 | EFO_0022246 | |
| Disease | Ovarian Failure, Premature | 3.83e-03 | 21 | 130 | 2 | C0085215 | |
| Disease | Seckel syndrome | 4.20e-03 | 22 | 130 | 2 | C0265202 | |
| Disease | brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement | 4.20e-03 | 22 | 130 | 2 | EFO_0004277, EFO_0006790, EFO_0006792, EFO_0006797, EFO_0006798 | |
| Disease | portal hypertension (biomarker_via_orthology) | 4.20e-03 | 22 | 130 | 2 | DOID:10762 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EIYGAVKGMSASDMK | 1396 | Q8WWZ7 | |
| KSTDLTVGKIYAAMM | 1946 | O00555 | |
| LEKDIKTSYIMDHMI | 16 | O14727 | |
| KLTIMLEKLGMDYDG | 276 | Q8IV48 | |
| YLSMIMESKFREKLE | 131 | A0FGR9 | |
| DEQYLMASDMAGKIK | 381 | Q8WV16 | |
| EHYEKKMRDLMASTV | 316 | O15013 | |
| AVLADVSYLMAMEKS | 6 | P35626 | |
| LMDETMKELKAYKSE | 81 | P02649 | |
| SLKGYEVTDMMQKAL | 186 | P54284 | |
| GEYKMALKNLEMISD | 241 | O60239 | |
| MDFGTMKDKIVANEY | 181 | Q9H8M2 | |
| MENLVAYAKKVEGDM | 626 | Q92793 | |
| MTEIEKYASKVDHVM | 371 | Q9NRK6 | |
| MVDVLYAKVHMKDGS | 261 | Q8N9N2 | |
| MMKEADKDGDRTIDY | 151 | Q8TD86 | |
| KSDVSSLIFLMKDYM | 106 | O15519 | |
| LKGYEVTDMMQKALF | 291 | Q08289 | |
| AVLADVSYLMAMEKS | 6 | P25098 | |
| LDLLYGMVSKKNLME | 361 | O14617 | |
| LEALNDYKTMFMSGK | 321 | Q9Y483 | |
| SDMDYLKSKMVKAGS | 206 | Q9Y4C8 | |
| LAKDIMKDIGYSDIM | 56 | Q9NRG1 | |
| TDFEKGFIMAEVMKY | 336 | Q9NTK5 | |
| IFDVESMKKAMVEYE | 676 | P09874 | |
| MTEKMSSFLYIGDIV | 1 | Q14571 | |
| DVEYISETKIMKKSM | 631 | Q86VD1 | |
| TGKVKDFLTDLMMSE | 386 | Q5VWQ8 | |
| GLKYSMELDEMDEVK | 896 | Q5HY64 | |
| AMEKEMKFYQGSVDR | 46 | Q6ZMV7 | |
| VEIMKYSMLGTYSDE | 741 | Q9UJA3 | |
| VSEAMMKSLKYCDVD | 996 | Q3B7T1 | |
| EQMTYGISSEKMLKA | 496 | O15111 | |
| LKKDVDAAYMGRMDL | 251 | Q5XKE5 | |
| SSMVLTKMKEIAEAY | 121 | P54652 | |
| SMVLTKMKEIAEAYL | 121 | P0DMV9 | |
| LIKEPSVDDYMGMIK | 146 | Q02556 | |
| TALSEEMKDKGGYMS | 326 | Q9NST1 | |
| NKDGYITKEEMLDIM | 171 | Q6PIL6 | |
| MKYMFTGDSVKEQVE | 1301 | Q9ULK4 | |
| TMKDYSKLGVHDMND | 36 | Q5T7B8 | |
| KIMGMEFSEEKIQYL | 116 | O15264 | |
| MELHRKEALTKDMEY | 101 | P30519 | |
| LMSVKEMAKGITYDD | 126 | Q9UJV9 | |
| MPSLDKVKEMGSSYE | 76 | Q5TGP6 | |
| KVKEMGSSYEYIEDM | 81 | Q5TGP6 | |
| AKMDEIGNHYTEMVK | 451 | Q8WVV4 | |
| GMDAMKGTTTIEKYD | 436 | Q9C0H6 | |
| GGAYIAKEEIMKAMT | 436 | Q5XG87 | |
| SKIMISDFGLSKMED | 156 | Q14012 | |
| FEMYKEQVKKMGEES | 96 | Q9UQ26 | |
| MKMGYEEVSQKFTSI | 106 | Q96BN8 | |
| MDMFQKVEKIGEGTY | 1 | Q00526 | |
| ELLYTYKEGMEKESM | 896 | A4FU69 | |
| KDMGSAGMVVYSIEK | 151 | Q9BYE9 | |
| MGDIKSNMSKLIYES | 2276 | Q9ULT8 | |
| RTLDDMSEMVKKLYS | 481 | Q8WYA0 | |
| NFAMSYVKLMKEDGT | 526 | Q92608 | |
| VDKYSLIMKVQDMDG | 316 | Q14574 | |
| DMKETKYTVDKRFGM | 251 | P19525 | |
| ESLESMMYGKKVLSQ | 1701 | Q8TD26 | |
| MGKMVEVDIYESGKH | 471 | Q5VV42 | |
| KSEMKEYLVGDYSMG | 1311 | Q5TH69 | |
| SAGENYERKEFVKMM | 2086 | A8TX70 | |
| YDVMKDFEEMRKAGI | 56 | P09669 | |
| SKEYSLEKAMEKMIT | 896 | Q8WXX0 | |
| PKTVKLFDDMMYELT | 21 | Q9NSG2 | |
| MDPEMETRYSVEKEK | 616 | O60266 | |
| LKESGMTMEELKYSL | 226 | P20851 | |
| KMSELPSYGEMAAEK | 881 | Q8NDI1 | |
| ELMKSKYSDITIMFE | 176 | Q14353 | |
| KAMTLMEYLIKTGSE | 76 | Q9Y6I3 | |
| GMLKDNAMLEYLKIA | 181 | P15311 | |
| QDADEKFMEVMYGTK | 411 | P42892 | |
| TLTEEEAKMIGMSLY | 541 | Q5TBA9 | |
| GDEMVSLKDYCTRMK | 471 | P07900 | |
| SMVLTKMKEIAEAYL | 121 | P0DMV8 | |
| SGIMEDSAIKCEYML | 81 | O95718 | |
| SAMVLTKMKETAEAY | 146 | P11021 | |
| DVAADIAKYTSKMMD | 921 | Q9ULU4 | |
| SEAKLEEYTGTMMKI | 146 | O76038 | |
| EEYTGTMMKIFDRNK | 151 | O76038 | |
| YSEKESLSFMIDTMK | 256 | Q9H4I8 | |
| VCTLNMGDKKYEDME | 6 | Q99590 | |
| AYGKAGKMLVETSMI | 76 | Q9HBR0 | |
| AVSMLKQDYKEGEMT | 171 | P25789 | |
| MLKSVMQELEDYSEG | 736 | P0DJD0 | |
| SMVLTKMKEIAEAYL | 121 | P11142 | |
| KDESLVSKAMEYMFG | 311 | Q8NFH5 | |
| FSYKKMTVMEAVDLL | 66 | Q9UGB7 | |
| DGLEEVQKAEMKAYM | 101 | O75431 | |
| EMEGYMKAEVASDTL | 136 | A6NES4 | |
| EYEEMSEMKEGKACK | 546 | Q92834 | |
| MEDSYKDRTSLMKGA | 1 | Q496J9 | |
| EKILESSIPMEYAKM | 541 | Q9H7E2 | |
| AALEAMKDYTKAMDV | 436 | P31948 | |
| DYHDLMEITEKMVSG | 346 | Q15046 | |
| SRKEAEEEYGMKAMK | 376 | Q8IVG5 | |
| EEEYGMKAMKKESEG | 381 | Q8IVG5 | |
| YTDEDMLKYMKMTAT | 391 | Q8N6K7 | |
| SMYQMEVIFGKVKDA | 351 | A5D8V7 | |
| SLMMLDSKSKYVLDG | 736 | Q9UIU6 | |
| RSMKLMYKESGVFEG | 281 | Q8WTV0 | |
| KEAVAMESYAKALRM | 431 | P78371 | |
| EMDKREGKYDMGILD | 996 | Q9Y2G9 | |
| TEEARKAYKDMVAAM | 811 | Q93073 | |
| TMYEKKLNGILADEM | 631 | Q6ZRS2 | |
| LKEEIKMYMDHANEG | 761 | O00444 | |
| TMYEMETSGKIAKSQ | 136 | Q9Y619 | |
| TDNMMLEFYKKDGLR | 496 | Q17R89 | |
| MEYMETGSLEKLLAS | 96 | P57078 | |
| YNKDLLDKVMEMADG | 81 | Q96HQ2 | |
| KGLMTIYEDEMKQEI | 636 | Q70EK8 | |
| DKEYMKGVMRTKVDD | 206 | Q9Y4G8 | |
| KKEERMYAMKSSLED | 1461 | O15417 | |
| YEAQKMMAEIRGSKE | 141 | Q7M4L6 | |
| SDTTKEVEMMKAAYR | 871 | Q92574 | |
| TVGFDKKDMMDIKYR | 1476 | Q96RL7 | |
| KCSYDGVEDKRIMGM | 476 | Q9H2E6 | |
| ADDMAMEKGKYVGEL | 56 | Q13426 | |
| DSKMFAEIMMKIEEY | 56 | Q8WWY3 | |
| QLGMEAKVKTYDMTA | 1456 | Q709C8 | |
| YKGITAKPVSEDMME | 21 | Q5VVX9 | |
| MGFIMEKEQSYKDAV | 1241 | Q8NDW8 | |
| SLDILKGKVMASMFY | 1956 | P27708 | |
| MAEMKTEDGKVEKHY | 26 | O75436 | |
| MDSAEKIMIYSIKEK | 456 | Q6ZR37 | |
| IYGTKKFMQELTEML | 546 | Q9H1V8 | |
| SMLESEILAGKMYIQ | 981 | Q502W6 | |
| EMYFSVDMEILGKVT | 721 | Q9H0M0 | |
| MGDKVASEALMKYHI | 291 | Q15063 | |
| GAITAKELYTMMTDK | 181 | P40818 | |
| YLEMEFKEAITAIMK | 716 | Q14966 | |
| RLYELAMKMSEKETS | 586 | Q8NFW9 |